<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Brain Behav</journal-id>
<journal-id journal-id-type="iso-abbrev">Brain Behav</journal-id>
<journal-id journal-id-type="doi">10.1002/(ISSN)2157-9032</journal-id>
<journal-id journal-id-type="publisher-id">BRB3</journal-id>
<journal-title-group>
<journal-title>Brain and Behavior</journal-title>
</journal-title-group>
<issn pub-type="epub">2162-3279</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30656857</article-id>
<article-id pub-id-type="pmc">6379516</article-id>
<article-id pub-id-type="doi">10.1002/brb3.1199</article-id>
<article-id pub-id-type="publisher-id">BRB31199</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Original Research</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Original Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Association between miRNAs expression and cognitive performances of Pediatric Multiple Sclerosis patients: A pilot study</article-title>
<alt-title alt-title-type="left-running-head">LIGUORI et al.</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes" id="brb31199-cr-0001">
<name>
<surname>Liguori</surname>
<given-names>Maria</given-names>
</name>
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4338-0392</contrib-id>
<address>
<email>maria.liguori@cnr.it</email>
<email>maria.liguori@ba.itb.cnr.it</email>
</address>
<xref ref-type="aff" rid="brb31199-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="brb31199-cr-0002">
<name>
<surname>Nuzziello</surname>
<given-names>Nicoletta</given-names>
</name>
<xref ref-type="aff" rid="brb31199-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="brb31199-cr-0003">
<name>
<surname>Simone</surname>
<given-names>Marta</given-names>
</name>
<xref ref-type="aff" rid="brb31199-aff-0002">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="brb31199-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="brb31199-cr-0004">
<name>
<surname>Amoroso</surname>
<given-names>Nicola</given-names>
</name>
<xref ref-type="aff" rid="brb31199-aff-0004">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="brb31199-aff-0005">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="brb31199-cr-0005">
<name>
<surname>Viterbo</surname>
<given-names>Rosa Gemma</given-names>
</name>
<xref ref-type="aff" rid="brb31199-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="brb31199-cr-0006">
<name>
<surname>Tangaro</surname>
<given-names>Sabina</given-names>
</name>
<xref ref-type="aff" rid="brb31199-aff-0005">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="brb31199-cr-0007">
<name>
<surname>Consiglio</surname>
<given-names>Arianna</given-names>
</name>
<xref ref-type="aff" rid="brb31199-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="brb31199-cr-0008">
<name>
<surname>Giordano</surname>
<given-names>Paola</given-names>
</name>
<xref ref-type="aff" rid="brb31199-aff-0006">
<sup>6</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="brb31199-cr-0009">
<name>
<surname>Bellotti</surname>
<given-names>Roberto</given-names>
</name>
<xref ref-type="aff" rid="brb31199-aff-0004">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="brb31199-aff-0005">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="brb31199-cr-0010">
<name>
<surname>Trojano</surname>
<given-names>Maria</given-names>
</name>
<xref ref-type="aff" rid="brb31199-aff-0003">
<sup>3</sup>
</xref>
</contrib>
</contrib-group>
<aff id="brb31199-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">National Research Council</named-content>
<named-content content-type="organisation-division">Bari Unit</named-content>
<institution>Institute of Biomedical Technologies</institution>
<named-content content-type="city">Bari</named-content>
<country country="IT">Italy</country>
</aff>
<aff id="brb31199-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Unit for Severe Disabilities in Developmental Age and Young Adults, Developmental Neurology and Neurorehabilitation</named-content>
<institution>Scientific Institute IRCCS E. Medea</institution>
<named-content content-type="city">Brindisi</named-content>
<country country="IT">Italy</country>
</aff>
<aff id="brb31199-aff-0003">
<label><sup>3</sup></label>
<named-content content-type="organisation-division">Department of Basic Sciences, Neurosciences and Sense Organs</named-content>
<institution>University of Bari</institution>
<named-content content-type="city">Bari</named-content>
<country country="IT">Italy</country>
</aff>
<aff id="brb31199-aff-0004">
<label><sup>4</sup></label>
<named-content content-type="organisation-division">Dipartimento Interateneo di Fisica “M. Merlin”</named-content>
<institution>Università degli studi di Bari “A. Moro”</institution>
<named-content content-type="city">Bari</named-content>
<country country="IT">Italy</country>
</aff>
<aff id="brb31199-aff-0005">
<label><sup>5</sup></label>
<institution>Istituto Nazionale di Fisica Nucleare, Sezione di Bari</institution>
<named-content content-type="city">Bari</named-content>
<country country="IT">Italy</country>
</aff>
<aff id="brb31199-aff-0006">
<label><sup>6</sup></label>
<named-content content-type="organisation-division">General Paediatric Unit “B. Trambusti”, Azienda Policlinico‐Giovanni XXIII</named-content>
<institution>University of Bari</institution>
<named-content content-type="city">Bari</named-content>
<country country="IT">Italy</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break></break>
Maria Liguori, Institute of Biomedical Technologies, National Research Council, Bari, Italy.<break></break>
Emails: <email>maria.liguori@cnr.it</email>; <email>maria.liguori@ba.itb.cnr.it</email><break></break></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>17</day>
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<month>2</month>
<year>2019</year>
</pub-date>
<volume>9</volume>
<issue>2</issue>
<issue-id pub-id-type="doi">10.1002/brb3.2019.9.issue-2</issue-id>
<elocation-id>e01199</elocation-id>
<history>
<date date-type="received">
<day>12</day>
<month>11</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>28</day>
<month>11</month>
<year>2018</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2019 Published by Wiley Periodicals, Inc. <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2019 The Authors. <italic>Brain and Behavior</italic> published by Wiley Periodicals, Inc.</copyright-statement>
<license license-type="creativeCommonsBy">
<license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="file:BRB3-9-e01199.pdf" xlink:type="simple"></self-uri>
<abstract id="brb31199-abs-0001">
<title>Abstract</title>
<sec id="brb31199-sec-0001">
<title>
<bold>Introduction</bold>
</title>
<p>The Pediatric onset of Multiple Sclerosis (PedMS) occurs in up to 10% of all cases. Cognitive impairment is one of the frequent symptoms, exerting severe impact in patients’ quality of life and school performances. The underlying pathogenic mechanisms are not fully understood, and molecular markers predictive of cognitive dysfunctions need to be identified. On these grounds, we searched for molecular signature/s (i.e., miRNAs and target genes) associated with cognitive impairment in a selected population of PedMS patients. Additionally, changes of their regional brain volumes associated with the miRNAs of interest were investigated.</p>
</sec>
<sec id="brb31199-sec-0002">
<title>Methods</title>
<p>Nineteen PedMS subjects received a full cognitive evaluation; total RNA from peripheral blood samples was processed by next‐generation sequencing followed by a bioinformatics/biostatistics analysis.</p>
</sec>
<sec id="brb31199-sec-0003">
<title>Results</title>
<p>The expression of 11 miRNAs significantly correlated with the scores obtained at different cognitive tests; among the others, eight miRNAs correlated with the Trail Making Tests. The computational target prediction identified 337 genes targeted by the miRNAs of interest; a tangled network of molecular connections was hypothesized, where genes like <italic>BST1, NTNG2, SPTB, </italic>and <italic>STAB1</italic>, already associated with cognitive dysfunctions, were nodes of the net. Furthermore, the expression of some miRNAs significantly correlated with cerebral volumes, for example, four miRNAs with the cerebellum cortex.</p>
</sec>
<sec id="brb31199-sec-0004">
<title>Conclusions</title>
<p>As far as we know, this is the first evaluation exploring miRNAs in the cognitive performances of PedMS. Although none of these results survived the multiple tests’ corrections, we believe that they may represent a step forward the identification of biomarkers useful for monitoring and targeting the onset/progression of cognitive impairments in MS.</p>
</sec>
</abstract>
<kwd-group kwd-group-type="author-generated">
<kwd id="brb31199-kwd-0001">bioinformatics</kwd>
<kwd id="brb31199-kwd-0002">circulating biomarkers</kwd>
<kwd id="brb31199-kwd-0003">cognitive dysfunctions</kwd>
<kwd id="brb31199-kwd-0004">gene targets</kwd>
<kwd id="brb31199-kwd-0005">HT‐NGS</kwd>
<kwd id="brb31199-kwd-0006">miRNAs</kwd>
<kwd id="brb31199-kwd-0007">molecular pathogenesis</kwd>
<kwd id="brb31199-kwd-0008">MRI regional volumes</kwd>
<kwd id="brb31199-kwd-0009">networks</kwd>
<kwd id="brb31199-kwd-0010">pediatric multiple sclerosis</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>Fondazione Italiana Sclerosi Multipla</funding-source>
<award-id>2014/R/10</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="2"></fig-count>
<table-count count="4"></table-count>
<page-count count="10"></page-count>
<word-count count="21149"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>component-id</meta-name>
<meta-value>brb31199</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>February 2019</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:5.5.9 mode:remove_FC converted:19.02.2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<p content-type="self-citation">
<mixed-citation id="brb31199-cit-1001" publication-type="journal">
<string-name>
<surname>Liguori</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Nuzziello</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Simone</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Association between miRNAs expression and cognitive performances of Pediatric Multiple Sclerosis patients: A pilot study</article-title>. <source xml:lang="en"/>Brain Behav. <year>2019</year>;<volume>9</volume>:<elocation-id>e01199</elocation-id>
<pub-id pub-id-type="doi">10.1002/brb3.1199</pub-id>
</mixed-citation>
</p>
<fn-group id="brb31199-ntgp-0001">
<fn fn-type="funding" id="brb31199-note-0001">
<p>
<bold>Funding information</bold>
</p>
<p>The study was fully supported by Fondazione Italiana Sclerosi Multipla (FISM) Grant no. 2014/R/10.</p>
</fn>
<fn id="brb31199-note-0008">
<p>[Correction added on 7 February 2019, after first online publication: the 2nd affiliation and affiliations linked to the authors Rosa Gemma Viterbo, Sabina Tangaro, Roberto Bellotti and Maria Trojano have been corrected.]</p>
</fn>
</fn-group>
</notes>
</front>
<body>
<sec id="brb31199-sec-0005">
<label>1</label>
<title>INTRODUCTION</title>
<p>Multiple sclerosis (MS) is a demyelinating autoimmune disease of the central nervous system (CNS) that usually affects young adults (Olsson, Barcellos, &amp; Alfredsson, <xref ref-type="ref" rid="brb31199-bib-0044">2016</xref>), although the onset during childhood and adolescence is being increasingly recognized. Pediatric MS (PedMS) represents up to 10% of all MS cases (Banwell, <xref ref-type="ref" rid="brb31199-bib-0008">2014</xref>; Chitnis, Glanz, Jaffin, &amp; Healy, <xref ref-type="ref" rid="brb31199-bib-0013">2009</xref>), the most prevalent course being the relapsing‐remitting (RR) with the higher relapse rate observed in the first 2 years of the disease course (Banwell, Ghezzi, Bar‐Or, Mikaeloff, &amp; Tardieu, <xref ref-type="ref" rid="brb31199-bib-0009">2007</xref>; Waldman et al., <xref ref-type="ref" rid="brb31199-bib-0056">2016</xref>).</p>
<p>Among the first clinical evidences, the cognitive impairment is one of the most frequent in PedMS as in the adult form of the disease, exerting severe impact in patients’ quality of life and school performances. The pathogenic mechanisms underlying the neuropsychiatric and cognitive disorders in PedMS are not fully understood yet; they may be the result of the irreversible impact that inflammation (demyelination) and/or neurodegeneration produce on the ongoing maturation of the cognitive pathways (Amato et al., <xref ref-type="ref" rid="brb31199-bib-0003">2004</xref>, <xref ref-type="ref" rid="brb31199-bib-0006">2007</xref>; Di Filippo, Portaccio, Mancini, &amp; Calabresi, <xref ref-type="ref" rid="brb31199-bib-0019">2018</xref>). This should be particularly plausible for the language skills that are more commonly involved in PedMS than in adult patients (Nunan‐Saah, Paulraj, Waubant, Krupp, &amp; Gomez, <xref ref-type="ref" rid="brb31199-bib-0042">2015</xref>).</p>
<p>Advanced structural and functional MRI techniques provided interesting hypotheses about the mechanisms possibly implicated in the cognitive dysfunctions of PedMS. Among the other findings, structural damage to a set of posterior brain regions suggested that, through focal lesions and demyelinated plaques, degenerated axons may lead to deafferentation and atrophy, thus evoking a pivotal role of white matter (WM) distress, other than the gray matter (GM) loss, in the pathogenesis of the cognitive symptoms (Rocca et al., <xref ref-type="ref" rid="brb31199-bib-0047">2014</xref>).</p>
<p>On the other hand, molecular markers predictive of neuropsychological dysfunctions’ occurrence and progression still need to be identified in pediatric and in adult MS. microRNAs (miRNAs), a class of small noncoding RNA, seem to play a key role in complex diseases like MS as circulating regulatory factors that may serve, for example, as biomarkers of clinical activity (Baulina et al., <xref ref-type="ref" rid="brb31199-bib-0010">2018</xref>; Vistbakka, Sumelahti, Lehtimäki, Elovaara, &amp; Hagman, <xref ref-type="ref" rid="brb31199-bib-0055">2018</xref>) or response to treatments (Fenoglio et al., <xref ref-type="ref" rid="brb31199-bib-0022">2016</xref>; Niwald, Migdalska‐Sęk, Brzeziańska‐Lasota, &amp; Miller, <xref ref-type="ref" rid="brb31199-bib-0041">2017</xref>; Sáenz‐Cuesta et al., <xref ref-type="ref" rid="brb31199-bib-0050">2018</xref>). miRNA networks are actively involved in many neuropsychiatric disorder (Saab &amp; Mansuy, <xref ref-type="ref" rid="brb31199-bib-0048">2014</xref>; Xu, Hsu, Karayiorgou, &amp; Gogos, <xref ref-type="ref" rid="brb31199-bib-0059">2012</xref>), so the possibility that they may contribute to the pathogenic mechanisms underlying the cognitive disfunctions in MS is more than plausible. Furthermore, the identification of circulating miRNAs implicated in the occurrence of these disabling symptoms may be a valuable source of information also in the prospective of designating novel target for more efficient therapeutic efforts.</p>
<p>In order to investigate the role of miRNAs in the very early stages of MS, we performed an extensive analysis of miRNAs and mRNAs profiles derived from the peripheral blood samples of a selected PedMS population and a pediatric group of healthy subjects, and we identified 13 miRNAs and 4,306 mRNAs whose expression resulted significantly different between the two groups (Liguori, Nuzziello, Licciulli, et al., <xref ref-type="ref" rid="brb31199-bib-0037">2018b</xref>). No peculiar molecular signatures resulted associated with the PedMS clinical disability (EDSS) or cognitive dysfunctions, as simply categorized into cognitively impaired (CI) and preserved (CP) patients, according to international criteria (Amato et al., <xref ref-type="ref" rid="brb31199-bib-0004">2014</xref>).</p>
<p>However, given the very early assessment of their cognitive performances and since a detailed neuropsychological examination was available for these patients, we decided to look more deeply into this issue by searching for significant associations (if any) between the expressions of these miRNAs and the individual scores of the performed neuropsychological tests.</p>
<p>The main purpose of this analysis was to possibly identify those circulating miRNAs and their target genes that may be responsible for the pathogenic mechanism/s involved in the neuropsychological damage observed in PedMS, also providing a selection of circulating biomarkers (miRNAs) best suited for more target therapeutic efforts.</p>
<p>Given the availability of conventional MRI data, additional aim of this observation was to search for possible associations between the expression of the miRNAs of interest and the regional brain volumes of PedMS patients, following the intriguing hypothesis that miRNAs may also exert an impact in the genetic architecture of the neurodevelopment (Ziats &amp; Rennert, <xref ref-type="ref" rid="brb31199-bib-0062">2014</xref>).</p>
</sec>
<sec id="brb31199-sec-0006">
<label>2</label>
<title>PATIENTS AND METHODS</title>
<p>This report is part of a multidisciplinary and longitudinal investigation performed on 19 Caucasian patients with PedMS (Banwell et al., <xref ref-type="ref" rid="brb31199-bib-0009">2007</xref>; Waubant et al., <xref ref-type="ref" rid="brb31199-bib-0057">2009</xref>) recruited within 5 years from the onset and followed up at the Department of Basic Sciences, Neurosciences and Sense Organs, University of Bari (Liguori, Nuzziello, Licciulli, et al., <xref ref-type="ref" rid="brb31199-bib-0037">2018b</xref>). Nine patients were under interferon β‐1a treatment at the time of the study entry; they all received neurological examination (EDSS; Kurtzke, <xref ref-type="ref" rid="brb31199-bib-0035">1983</xref>) and neuropsychological evaluation by using a battery of validated tests exploring the following cognitive domains (Amato et al., <xref ref-type="ref" rid="brb31199-bib-0005">2010</xref>):
<list id="brb31199-list-0001" list-type="order"><list-item><p>Verbal learning and delayed recall through the Selective Reminding Test (SRT) and Selective Reminding Test—Delayed (SRT‐D) from Rao's battery.</p></list-item><list-item><p>Visuospatial learning through the Spatial Recall Test (SPART) and Spatial Recall Test—Delayed (SPART‐D) from Rao's battery.</p></list-item><list-item><p>Complex attention through the Symbol Digit Modalities Test (SDMT) from Rao's battery and the Trail Making Test (TMT‐A and TMT‐B).</p></list-item><list-item><p>Planning of executive functions through the Tower of London Test (TOL).</p></list-item><list-item><p>Expressive language through a semantic and phonemic verbal fluency test and an oral denomination test from the Aachener Aphasie Test.</p></list-item></list>
</p>
<p>Depression and fatigue were self‐assessed through the Children Depression Inventory (CDI) and the Fatigue Severity Scale (FSS), respectively. According to published guidelines, cognitive impairment (CI) was considered after a failure of at least three tests (Amato et al., <xref ref-type="ref" rid="brb31199-bib-0005">2010</xref>).</p>
<p>The study was approved by the Ethics Committee of Azienda Ospedaliera Policlinico, University of Bari. Since the study subjects were all under the age of 18 years, their legal tutors signed written informed consent forms (according to the Declaration of Helsinki) at the time of the enrollment.</p>
<sec id="brb31199-sec-0007">
<label>2.1</label>
<title>Molecular analysis</title>
<p>Peripheral blood samples were collected from each PedMS patient at the study entry; total RNA isolation was followed by high‐throughput next‐generation sequencing (HT‐NGS) of both miRNAs and mRNAs compounds, and by qRT‐PCR validation only of the 13 miRNAs whose expressions resulted significantly different (DE) from those of a population of pediatric healthy controls (Liguori, Nuzziello, Licciulli, et al., <xref ref-type="ref" rid="brb31199-bib-0037">2018b</xref>).</p>
<p>Here, we used the expression data of the significant miRNAs (let‐7a‐5p, let‐7b‐5p, miR‐25‐3p, miR‐99b‐5p, miR‐125a‐5p, miR‐148b‐3p, miR‐181a‐5p, miR‐182‐5p, miR‐185‐5p, miR‐221‐3p, miR‐320a, miR‐652‐3p, and miR‐942‐5p), as resulted from the qRT‐PCR analysis according to the 2<sup>−ΔΔCt</sup> method in a previous study (Liguori, Nuzziello, Licciulli, et al., <xref ref-type="ref" rid="brb31199-bib-0037">2018b</xref>).</p>
</sec>
<sec id="brb31199-sec-0008">
<label>2.2</label>
<title>Statistical analysis</title>
<p>Speaman rank‐order correlation test was applied in order to evaluate the following: (a) the correlations between the individual scores obtained during the neuropsychological (NPS) evaluation and the expression of each miRNA (fold change); (b) the correlation between the regional brain volumes and the miRNAs expressions; and (c) the correlations between the brain volumes and the NPS scores. Results were considered significant at <italic>p</italic> &lt; 0.05. Adjustments for false discovery rate (FDR) for age at blood sample and gender were applied.</p>
</sec>
<sec id="brb31199-sec-0009">
<label>2.3</label>
<title>Target genes and pathway analysis</title>
<p>Starting from the results of the DE analysis performed on the two datasets (sRNAs and mRNAs)(Liguori, Nuzziello, Licciulli, et al., <xref ref-type="ref" rid="brb31199-bib-0037">2018b</xref>), the relationships between DE miRNAs and DE target genes were investigated through a bioinformatics approach. Their interactions were selected using two databases of experimentally validated bindings (miRTarBase and DIANA‐Tarbase). In order to consider the most reliable information about the interactions between the significant miRNAs and their target genes, we selected those bindings that were confirmed at least by the luciferase assay, among others reporter tests. Functional and pathway enrichment analysis of identified target DE genes was performed using the Database for Annotation, Visualization and Integrated Discovery (DAVID v6.8, <ext-link ext-link-type="uri" xlink:href="http://david.abcc.ncifcrf.gov">http://david.abcc.ncifcrf.gov</ext-link>) tool. DAVID is a gene functional enrichment program that provides a large series of functional annotation tools and pathway databases (e.g., KEGG, BioCarta, Reactome databases). The statistical significance was determined using the one‐tailed Fisher's exact test followed by the Benjamini correction; adjusted <italic>p</italic>‐value &lt;0.05 was set as the threshold value. Details of methods and software used for the analysis have been already published (Liguori, Nuzziello, Introna, et al., <xref ref-type="ref" rid="brb31199-bib-0036">2018a</xref>; Liguori, Nuzziello, Licciulli, et al., <xref ref-type="ref" rid="brb31199-bib-0037">2018b</xref>).</p>
</sec>
<sec id="brb31199-sec-0010">
<label>2.4</label>
<title>Regional MRI</title>
<p>MRI scan was acquired at the study entry (T0) in all the 19 PedMS; however, only the images of 12 of them were available for this analysis. MRI examinations were performed with a 1,5 Tesla GE Signa MR System. Conventional sequences, consisting of dual‐echo, in order to obtain a T2‐weighted image, and fluid‐attenuated inversion recovery (FLAIR), were acquired in axial and coronal orientation covering the whole brain. Double fast spin‐echo sequence (TR/TE1/TE2, 2,100 = 12 = 96 ms; matrix, 345,512) and the FLAIR sequence (TR/TE, 8,152 = 102 ms; matrix, 256,256) were performed with 20 slices, 5 mm thickness, 1:0 mm interslice gap, and 24 cm FOV. MRI data were processed with the publicly available brain segmentation tool FreeSurfer v.5.1 in order to obtain a 181‐feature representation. The processing pipeline provides, for each subject, GM and WM volumes of subcortical brain structures along with the intracranial volume in mm<sup>3</sup>; in addition, FreeSurfer yields the average thickness of specific cerebral regions. Data were initially cleaned by removing constant features; the remaining data (a matrix with 12 subjects and 150 features) were standardized in order to have null average and unitary variance.</p>
</sec>
</sec>
<sec id="brb31199-sec-0011">
<label>3</label>
<title>RESULTS</title>
<p>The main demographic and clinical characteristics of the PedMS population are summarized in Table <xref ref-type="table" rid="brb31199-tbl-0001">1</xref> and detailed in Liguori, Nuzziello, Licciulli, et al. (<xref ref-type="ref" rid="brb31199-bib-0037">2018b</xref>). Seven PedMS patients failed at least three tests so were classified as CI; 11 subjects were described as CP; one patient refused to be tested. No significant differences were found between the clinical and demographic features of CP and CI PedMS patients (<italic>p</italic> &gt; 0.05), and no molecular profiles resulted associated with these two phenotypes (Liguori, Nuzziello, Licciulli, et al., <xref ref-type="ref" rid="brb31199-bib-0037">2018b</xref>).</p>
<table-wrap id="brb31199-tbl-0001" orientation="portrait" position="float" xml:lang="en">
<label>Table 1</label>
<caption>
<p>Demographic and clinical features of the PedMS population</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top"></th>
<th align="left" colspan="1" rowspan="1" valign="top">PedMS (19)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Age at onset (years, mean ± <italic>SD</italic>)</td>
<td align="left" colspan="1" rowspan="1">12.6 ± 3.2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Female/male</td>
<td align="left" colspan="1" rowspan="1">10/9</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Age (years, mean ± <italic>SD</italic>)</td>
<td align="left" colspan="1" rowspan="1">15.5 ± 2.7</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Disease duration (years, mean ± <italic>SD</italic>)</td>
<td align="left" colspan="1" rowspan="1">2.8 ± 3.3</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Disease course</td>
<td align="left" colspan="1" rowspan="1">RR</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">EDSS (median, range)</td>
<td align="left" colspan="1" rowspan="1">3 (1.5–6)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Disease‐modifying treatment (yes/no)</td>
<td align="left" colspan="1" rowspan="1">9/10</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Education (years, mean ± <italic>SD</italic>)</td>
<td align="left" colspan="1" rowspan="1">9.6 ± 2.5</td>
</tr>
<tr>
<td align="left" colspan="2" rowspan="1">Verbal memory</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">SRT‐LTS (mean ± <italic>SD</italic>)</td>
<td align="left" colspan="1" rowspan="1">35.4 ± 14.8</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">SRT‐CLTR (mean ± <italic>SD</italic>)</td>
<td align="left" colspan="1" rowspan="1">27.2 ± 15.7</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">SRT‐D (median, range)</td>
<td align="left" colspan="1" rowspan="1">7.5 (4–12)</td>
</tr>
<tr>
<td align="left" colspan="2" rowspan="1">Visual‐spatial memory</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">SPART (mean ± <italic>SD</italic>)</td>
<td align="left" colspan="1" rowspan="1">21.7 ± 4.9</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">SPART‐D (median, range)</td>
<td align="left" colspan="1" rowspan="1">8 (4–10)</td>
</tr>
<tr>
<td align="left" colspan="2" rowspan="1">Attention and IPS</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">SDMT (mean ± <italic>SD</italic>)</td>
<td align="left" colspan="1" rowspan="1">41.8 ± 12.8</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">TMT‐A (mean ± <italic>SD</italic>)</td>
<td align="left" colspan="1" rowspan="1">41.4 ± 13.7</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">TMT‐B (median, range)</td>
<td align="left" colspan="1" rowspan="1">77.5 (38–151)</td>
</tr>
<tr>
<td align="left" colspan="2" rowspan="1">Executive functioning</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">TOL (mean ± <italic>SD</italic>)</td>
<td align="left" colspan="1" rowspan="1">28 ± 4.8</td>
</tr>
<tr>
<td align="left" colspan="2" rowspan="1">Expressive language</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">SVFT (mean ± <italic>SD</italic>)</td>
<td align="left" colspan="1" rowspan="1">21.1 ± 11.9</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">PVFT (mean ± <italic>SD</italic>)</td>
<td align="left" colspan="1" rowspan="1">16.2 ± 7.7</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="brb31199-note-0005">
<p>LTS, long term storage; CTRL, consistent long term retrieval; SVFT, semantic verbal fluency test; PVFT, phonemic verbal fluency test.</p>
</fn>
</table-wrap-foot>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
<sec id="brb31199-sec-0012">
<label>3.1</label>
<title>miRNas and cognitive functions</title>
<p>The expression of 11/13 miRNAs correlated with the scores obtained in several neuropsychological tests (Table <xref ref-type="table" rid="brb31199-tbl-0002">2</xref>). Among the others, a panel composed of eight miRNAs inversely correlated with the scores obtained at the TMT‐A and TMT‐B tests (<italic>p</italic> &lt; 0.05). The verbal memory performances positively correlated with the expressions of miR‐182‐5p and miR‐942‐5p. The TOL test was significantly associated with the expressions of miR‐125a‐5p and miR‐221‐3p, whereas, in the domain of the expressive language, the SVFT test correlated significantly with miR‐181a‐5p. Finally, the higher expressions of miR‐320a correlated with the higher depression and the fatigue scores, and the latter also correlated with the expression of miR‐99b‐5p. None of these correlations remained significant after FDR corrections.</p>
<table-wrap id="brb31199-tbl-0002" orientation="portrait" position="float" xml:lang="en">
<label>Table 2</label>
<caption>
<p>Correlations between miRNAs expressions and the NPS scores</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="2" valign="top"></th>
<th align="left" colspan="3" rowspan="1" style="border-bottom:solid 1px #000000" valign="top">Verbal memory</th>
<th align="left" colspan="2" rowspan="1" style="border-bottom:solid 1px #000000" valign="top">Attention and IPS</th>
<th align="left" colspan="1" rowspan="1" style="border-bottom:solid 1px #000000" valign="top">Executive functions</th>
<th align="left" colspan="1" rowspan="1" style="border-bottom:solid 1px #000000" valign="top">Expressive language</th>
<th align="left" colspan="1" rowspan="1" style="border-bottom:solid 1px #000000" valign="top">Depression</th>
<th align="left" colspan="1" rowspan="1" style="border-bottom:solid 1px #000000" valign="top">Fatigue</th>
</tr>
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top">
SRT_LTS<break></break>
p‐values (<italic>r</italic>
<sub>s</sub>)
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
SRT_CLTR<break></break>
<italic>p</italic>‐values (<italic>r</italic>
<sub>s</sub>)
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
SRT_D<break></break>
<italic>p</italic>‐values (<italic>r</italic>
<sub>s</sub>)
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
TMT_A<break></break>
<italic>p</italic>‐values (<italic>r</italic>
<sub>s</sub>)
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
TMT_B<break></break>
<italic>p</italic>‐values (<italic>r</italic>
<sub>s</sub>)
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
TOL<break></break>
<italic>p</italic>‐values (<italic>r</italic>
<sub>s</sub>)
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
SVFT<break></break>
<italic>p</italic>‐values (<italic>r</italic>
<sub>s</sub>)
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
CDI<break></break>
<italic>p</italic>‐values (<italic>r</italic>
<sub>s</sub>)
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
FSS<break></break>
<italic>p</italic>‐values (<italic>r</italic>
<sub>s</sub>)
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">miR25_3p</td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="(" colspan="1" rowspan="1">0.027 (−0.52)</td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">miR125a_5p</td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="(" colspan="1" rowspan="1">0.013 (−0.57)</td>
<td align="char" char="(" colspan="1" rowspan="1">0.007 (−0.61)</td>
<td align="char" char="(" colspan="1" rowspan="1">0.048 (0.47)</td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">miR942_5p</td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="(" colspan="1" rowspan="1">0.05 (0.47)</td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="(" colspan="1" rowspan="1">0.032 (−0.51)</td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">miR221_3p</td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="(" colspan="1" rowspan="1">0.012 (−0.58)</td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">miR652_3p</td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="(" colspan="1" rowspan="1">0.021 (−0.54)</td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">miR182_5p</td>
<td align="char" char="(" colspan="1" rowspan="1">0.023 (0.53)</td>
<td align="char" char="(" colspan="1" rowspan="1">0.004 (0.64)</td>
<td align="char" char="(" colspan="1" rowspan="1">0.02 (0.54)</td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">miR185_5p</td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="(" colspan="1" rowspan="1">0.009 (−0.6)</td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">miR181a_5p</td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="(" colspan="1" rowspan="1">0.036 (0.49)</td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">miR320a</td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="(" colspan="1" rowspan="1">0.018 (−0.56)</td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="(" colspan="1" rowspan="1">0.038 (0–49)</td>
<td align="char" char="(" colspan="1" rowspan="1">0.039 (0.49)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">miR99b_5p</td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="(" colspan="1" rowspan="1">0.044 (−0.48)</td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="(" colspan="1" rowspan="1">0.038 (0.49)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">miR148b_3p</td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="(" colspan="1" rowspan="1">0.49 (−0.47)</td>
<td align="char" char="(" colspan="1" rowspan="1">0.012 (−0.58)</td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1"></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<title>Note</title>
<fn id="brb31199-note-0002">
<p>Speaman rank‐order correlation tests: <italic>p</italic> &lt; 0.05.</p>
</fn>
</table-wrap-foot>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
</sec>
<sec id="brb31199-sec-0013">
<label>3.2</label>
<title>miRNAs/mRNAs integrated analysis in cognitive performances</title>
<p>The computational analysis of the target predictions identified 337 DE genes targeted by the 11 miRNAs that significantly correlated with the NPS scores in our PedMS population. By looking at the top shared (at least by six miRNAs), a tangled network of molecular connections possibly underlying the cognitive abilities was built (Figure <xref ref-type="fig" rid="brb31199-fig-0001">1</xref>). As nodes of the net, <italic>BRI3, SPTB, CACNA1H, DIP2A, NTNg2, RGS6, IGF2BP2, KCNH2, RTN3, RAB11FIP5, and STAB1</italic> have been already reported associated with cognitive functions (Table <xref ref-type="table" rid="brb31199-tbl-0003">3</xref>, see the <xref ref-type="sec" rid="brb31199-sec-0013">Discussion</xref> for comments). None of these correlations remained significant after FDR corrections.</p>
<fig fig-type="Figure" id="brb31199-fig-0001" orientation="portrait" position="float" xml:lang="en">
<label>Figure 1</label>
<caption>
<p>Hypothesized molecular network of cognitive abilities in PedMS. By using the connections between the first genes targeted by at least 6 out of the 11 miRNAs significantly associated with the NPS scores, the following network was composed (Cytoscape software 3.5.1). The node intensity color is proportional to the fold change values (red: under‐regulated; green: up‐regulated); the node size is proportional to the number of miRNA/mRNA connections. Please note that, for this representation, only down‐regulated genes were selected as target of up‐regulated miRNAs and <italic>vice versa </italic>for down‐regulated miRNAs</p>
</caption>
<graphic id="nlm-graphic-3" xlink:href="BRB3-9-e01199-g001"></graphic>
</fig>
<table-wrap id="brb31199-tbl-0003" orientation="portrait" position="float" xml:lang="en">
<label>Table 3</label>
<caption>
<p>The most significant miRNA's predicted targets (either up‐ and down‐regulated in our analysis)</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top">Predicted target genes</th>
<th align="left" colspan="1" rowspan="1" valign="top">Associated diseases with cognitive impairment</th>
<th align="left" colspan="1" rowspan="1" valign="top">Number of shared miRNAs</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>BRI3</italic>
</td>
<td align="left" colspan="1" rowspan="1">AD</td>
<td align="char" char="." colspan="1" rowspan="1">10</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>BST1</italic>
</td>
<td align="left" colspan="1" rowspan="1">Cognition in PD, autism</td>
<td align="char" char="." colspan="1" rowspan="1">10</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>RGS6</italic>
</td>
<td align="left" colspan="1" rowspan="1">AD</td>
<td align="char" char="." colspan="1" rowspan="1">9</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>CD72</italic>
</td>
<td align="left" colspan="1" rowspan="1">MS</td>
<td align="char" char="." colspan="1" rowspan="1">8</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>DIP2A</italic>
</td>
<td align="left" colspan="1" rowspan="1">AD, dyslexia, autism</td>
<td align="char" char="." colspan="1" rowspan="1">8</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>FCRL1</italic>
</td>
<td align="left" colspan="1" rowspan="1">MS, PD</td>
<td align="char" char="." colspan="1" rowspan="1">8</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>NTNG2</italic>
</td>
<td align="left" colspan="1" rowspan="1">Amygdala/cognition, bipolar disorder</td>
<td align="char" char="." colspan="1" rowspan="1">8</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>RAB11FIP5</italic>
</td>
<td align="left" colspan="1" rowspan="1">Depression</td>
<td align="char" char="." colspan="1" rowspan="1">8</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>SIRPB1</italic>
</td>
<td align="left" colspan="1" rowspan="1">Impulsive behavior, AD</td>
<td align="char" char="." colspan="1" rowspan="1">8</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>SPTB</italic>
</td>
<td align="left" colspan="1" rowspan="1">Cognitive processes</td>
<td align="char" char="." colspan="1" rowspan="1">8</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>ZBTB16</italic>
</td>
<td align="left" colspan="1" rowspan="1">AD, depression</td>
<td align="char" char="." colspan="1" rowspan="1">8</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>BACE2</italic>
</td>
<td align="left" colspan="1" rowspan="1">AD, neurodegenerative disorders</td>
<td align="char" char="." colspan="1" rowspan="1">7</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>BACH2</italic>
</td>
<td align="left" colspan="1" rowspan="1">MS</td>
<td align="char" char="." colspan="1" rowspan="1">7</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>CACNA1H</italic>
</td>
<td align="left" colspan="1" rowspan="1">MS</td>
<td align="char" char="." colspan="1" rowspan="1">7</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>IGF2BP2</italic>
</td>
<td align="left" colspan="1" rowspan="1">AD, PD</td>
<td align="char" char="." colspan="1" rowspan="1">7</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>RTN3</italic>
</td>
<td align="left" colspan="1" rowspan="1">AD</td>
<td align="char" char="." colspan="1" rowspan="1">7</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>SESN3</italic>
</td>
<td align="left" colspan="1" rowspan="1">Aging and degeneration</td>
<td align="char" char="." colspan="1" rowspan="1">7</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>TBXAS1</italic>
</td>
<td align="left" colspan="1" rowspan="1">MS, schizophrenia</td>
<td align="char" char="." colspan="1" rowspan="1">7</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>WARS</italic>
</td>
<td align="left" colspan="1" rowspan="1">Intellectual disability</td>
<td align="char" char="." colspan="1" rowspan="1">7</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>ADD2</italic>
</td>
<td align="left" colspan="1" rowspan="1">Schizophrenia</td>
<td align="char" char="." colspan="1" rowspan="1">6</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>FAM46A</italic>
</td>
<td align="left" colspan="1" rowspan="1">AD, depression</td>
<td align="char" char="." colspan="1" rowspan="1">6</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>FCRL5</italic>
</td>
<td align="left" colspan="1" rowspan="1">MS, AD</td>
<td align="char" char="." colspan="1" rowspan="1">6</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>FKBP1A</italic>
</td>
<td align="left" colspan="1" rowspan="1">Depression and response to therapy</td>
<td align="char" char="." colspan="1" rowspan="1">6</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>GNAS</italic>
</td>
<td align="left" colspan="1" rowspan="1">Animal cognition</td>
<td align="char" char="." colspan="1" rowspan="1">6</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>HES6</italic>
</td>
<td align="left" colspan="1" rowspan="1">Mood disorder</td>
<td align="char" char="." colspan="1" rowspan="1">6</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>KCNH2</italic>
</td>
<td align="left" colspan="1" rowspan="1">Schizophrenia</td>
<td align="char" char="." colspan="1" rowspan="1">6</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>MCF2L</italic>
</td>
<td align="left" colspan="1" rowspan="1">AD</td>
<td align="char" char="." colspan="1" rowspan="1">6</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>SHTN1</italic>
</td>
<td align="left" colspan="1" rowspan="1">MS</td>
<td align="char" char="." colspan="1" rowspan="1">6</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>SLC27A3</italic>
</td>
<td align="left" colspan="1" rowspan="1">Autism</td>
<td align="char" char="." colspan="1" rowspan="1">6</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>SPI1</italic>
</td>
<td align="left" colspan="1" rowspan="1">PD, AD</td>
<td align="char" char="." colspan="1" rowspan="1">6</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>STAB1</italic>
</td>
<td align="left" colspan="1" rowspan="1">Bipolar disorder</td>
<td align="char" char="." colspan="1" rowspan="1">6</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>STS</italic>
</td>
<td align="left" colspan="1" rowspan="1">ADHD</td>
<td align="char" char="." colspan="1" rowspan="1">6</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>TREM1</italic>
</td>
<td align="left" colspan="1" rowspan="1">AD</td>
<td align="char" char="." colspan="1" rowspan="1">6</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<title>Note</title>
<fn id="brb31199-note-0003">
<p>AD, Alzheimer's disease; ADHD, attention‐deficit and hyperactive disorder; MS, multiple sclerosis; PD, Parkinson's disease.</p>
</fn>
</table-wrap-foot>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
</sec>
<sec id="brb31199-sec-0014">
<label>3.3</label>
<title>miRNAs and regional volumes</title>
<p>The correlation analysis between brain volumes (as they were generated by the FreeSurfer pipeline) and the miRNAs expressions revealed several significant correlations (Table <xref ref-type="table" rid="brb31199-tbl-0004">4</xref>). Among the others, the expression of four miRNAs (miR‐25‐3p, miR‐125a‐5p, miR‐221‐3p, and miR‐320a) was significantly associated with total cerebellum cortex, whereas the total hippocampus volume correlated with miR‐182‐5p expression. None of these correlations remained significant after FDR corrections.</p>
<table-wrap id="brb31199-tbl-0004" orientation="portrait" position="float" xml:lang="en">
<label>Table 4</label>
<caption>
<p>Correlations between miRNAs expressions and regional brain volumes</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top"></th>
<th align="left" colspan="1" rowspan="1" valign="top">
Cerebellum cortex<break></break>
<italic>p</italic>‐values (<italic>r</italic>
<sub>s</sub>)
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
Hippocampus<break></break>
<italic>p</italic>‐values (<italic>r</italic>
<sub>s</sub>)
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
Corpus callosum<break></break>
<italic>p</italic>‐values (<italic>r</italic>
<sub>s</sub>)
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
R‐Frontal Lobe<break></break>
<italic>p</italic>‐values (<italic>r</italic>
<sub>s</sub>)
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
R‐Parietal Lobe<break></break>
<italic>p</italic>‐values (<italic>r</italic>
<sub>s</sub>)
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
L‐Temporal Lobe<break></break>
<italic>p</italic>‐values (<italic>r</italic>
<sub>s</sub>)
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
L‐Occipital Lobe<break></break>
<italic>p</italic>‐values (<italic>r</italic>
<sub>s</sub>)
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
R‐Occipital Lobe<break></break>
<italic>p</italic>‐values (<italic>r</italic>
<sub>s</sub>)
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
L‐Cingulate<break></break>
<italic>p</italic>‐values (<italic>r</italic>
<sub>s</sub>)
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
R‐Cingulate<break></break>
<italic>p</italic>‐values (<italic>r</italic>
<sub>s</sub>)
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">miR‐25‐3p</td>
<td align="left" colspan="1" rowspan="1">0.001 (−0.82)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">miR‐125a‐5p</td>
<td align="left" colspan="1" rowspan="1">0.036 (−0.61)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">0.042 (0.59)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">miR‐221‐3p</td>
<td align="left" colspan="1" rowspan="1">0.042 (0.59)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">miR‐652‐3p</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">0.042 (0.59)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">miR‐182‐5p</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">0.033 (−0.62)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">0.042 (−0.59)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">miR‐320a</td>
<td align="left" colspan="1" rowspan="1">0.02 (−0.66)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">0.017 (−0.67)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">0.033 (−0.62)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">miR‐148b‐3p</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">0.026 (−0.64)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">0.008 (−0.72)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<title>Note</title>
<fn id="brb31199-note-0004">
<p>Speaman rank‐order correlation tests: <italic>p</italic> &lt; 0.05.</p>
</fn>
</table-wrap-foot>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
</sec>
<sec id="brb31199-sec-0015">
<label>3.4</label>
<title>Pathway analysis</title>
<p>The most representative molecular functions (GO terms) was the protein binding (adjusted <italic>p</italic>‐value = 1.01e10<sup>−05</sup>); the analysis of the biological processes revealed that the significant genes were mostly involved in innate immune responses (adjusted <italic>p</italic>‐value = 4.9e10<sup>−08</sup>), translation (adjusted <italic>p</italic>‐value = 1.4e10<sup>−06</sup>), response and defense response to virus (adjusted <italic>p</italic>‐value = 8.2e10<sup>−11</sup> and 6.5e10<sup>−07</sup>, respectively) (Figure <xref ref-type="fig" rid="brb31199-fig-0002">2</xref>a). The most represented genes of cellular components were identified within the cytoplasm (adjusted <italic>p</italic>‐value = 0.00125) (Figure <xref ref-type="fig" rid="brb31199-fig-0002">2</xref>b).</p>
<fig fig-type="Figure" id="brb31199-fig-0002" orientation="portrait" position="float" xml:lang="en">
<label>Figure 2</label>
<caption>
<p>Frequencies of GO terms evoked by the significant target genes possibly implicated in PedMS cognitive dysfunctions. Histogram illustrates the GO terms (a: biological processes; b: cellular components<bold>)</bold> associated with assembled subnetworks (DAVID software v6.8). Please note that this analysis was performed by using all the predicted target genes (computationally or experimentally validated, see <xref ref-type="sec" rid="brb31199-sec-0002">Methods</xref> for details) of the significant 11 miRNAs correlating with the score of the different cognitive performances (either up‐ or down‐regulated genes)</p>
</caption>
<graphic id="nlm-graphic-5" xlink:href="BRB3-9-e01199-g002"></graphic>
</fig>
</sec>
<sec id="brb31199-sec-0016">
<label>3.5</label>
<title>Cognitive functions and regional volumes</title>
<p>Regional cerebral volumes significantly correlated with specific cognitive functions. In details, the volumes of the corpus callosum significantly correlated with the scores obtained at the TMT‐A (<italic>r</italic>
<sub>s</sub> = −0.64, <italic>p</italic> = 0.025), SPART‐D (<italic>r</italic>
<sub>s</sub> = 0.68, <italic>p</italic> = 0.015), and CDI (<italic>r</italic>
<sub>s</sub> = −0.6, <italic>p</italic> = 0.04) tests; the left temporal lobe significantly correlated with the scores obtained at the SRT‐LTS (<italic>r</italic>
<sub>s</sub> = 0.86, <italic>p</italic> = 0.0001), SRT‐CLTR (<italic>r</italic>
<sub>s</sub> = 0.75, <italic>p</italic> = 0.005), SDMT (<italic>r</italic>
<sub>s</sub> = 0.6, <italic>p</italic> = 0.04), SPART‐D (<italic>r</italic>
<sub>s</sub> = 0.6, <italic>p</italic> = 0.04), TOL (<italic>r</italic>
<sub>s</sub> = 0.63, <italic>p</italic> = 0.03), and CDI (<italic>r</italic>
<sub>s</sub> = −0.66, <italic>p</italic> = 0.02). Further significant correlations were the following: the cerebellum white matter with the scores obtained at the TOL test (<italic>r</italic>
<sub>s</sub> = −0.78, <italic>p</italic> = 0.003); the left frontal lobe with the SRT‐D (<italic>r</italic>
<sub>s</sub> = −0.73, <italic>p</italic> = 0.007); and the right occipital lobe with the SDMT test (<italic>r</italic>
<sub>s</sub> = 0.65, <italic>p</italic> = 0.021).</p>
</sec>
</sec>
<sec id="brb31199-sec-0017">
<label>4</label>
<title>DISCUSSION</title>
<p>Children and adolescents diagnosed with MS are particularly vulnerable to cognitive dysfunctions since the disease occurs during the growing phases of brain development, myelination, and maturation of the neural network. On the other hand, it has been recognized that growing brain still holds a basic reorganization until the adolescence, mostly due to elimination of synapses in the cortical circuits, increase in white matter, and changes in neurotransmitter systems, suggesting that an open window for peculiar changes in cognitive functions does exist both in healthy and in specific pathological conditions (Konrad, Firk, &amp; Uhlhaas, <xref ref-type="ref" rid="brb31199-bib-0033">2013</xref>).</p>
<p>In this report, by looking into the expression of 13 miRNAs that characterized a small but homogeneous group of PedMS patients (Liguori, Nuzziello, Licciulli, et al., <xref ref-type="ref" rid="brb31199-bib-0037">2018b</xref>), we narrowed down 11 miRNAs (miR‐25‐3p, miR‐99b‐5p, miR‐125a‐5p, miR‐148b‐3p, miR‐181a‐5p, miR‐182‐5p, miR‐185‐5p, miR‐221‐3p, miR‐320a, miR‐652‐3p, and miR‐942‐5p) that resulted significantly associated with different cognitive abilities. Of interest, eight miRNAs were found implicated in the domains of attention and information processing speed, frequent cognitive dysfunctions in PedMS that exert a significant impact in patients’ life and school performances (Ghezzi, Goretti, Portaccio, Roscio, &amp; Amato, <xref ref-type="ref" rid="brb31199-bib-0026">2010</xref>; Goretti et al., <xref ref-type="ref" rid="brb31199-bib-0028">2012</xref>; Julian et al., <xref ref-type="ref" rid="brb31199-bib-0031">2013</xref>). Some of the 11 miRNAs have been already reported associated with cognitive abilities in vitro or in vivo evaluations (Dutta et al., <xref ref-type="ref" rid="brb31199-bib-0020">2013</xref>; Kos et al., <xref ref-type="ref" rid="brb31199-bib-0034">2016</xref>; Olde Loohuis et al., <xref ref-type="ref" rid="brb31199-bib-0043">2012</xref>; Woldemichael &amp; Mansuy, <xref ref-type="ref" rid="brb31199-bib-0058">2016</xref>; Zhang, Chen, Zhang, &amp; Xu, <xref ref-type="ref" rid="brb31199-bib-0061">2017</xref>), whereas for others, the association is novel so far. Above all, in our view this preliminary evidence may represent a step forward the identification of molecular markers of cognitive impairment to monitor during the MS course, and it may help to hypothesize more focused pharmacological and rehabilitative strategies.</p>
<p>Mature miRNAs bind the target sites of protein‐coding genes that lead to the repression of their translation; in mammals, they are predicted to exert post‐transcriptional control on over 60% of the protein‐coding genes (Keller et al., <xref ref-type="ref" rid="brb31199-bib-0032">2011</xref>). A deregulation of miRNA expression seems to be involved in a broad spectrum of cellular and biological processes including developmental timing, hematopoiesis, organogenesis, apoptosis, and cell proliferation (Soltanzadeh‐Yamchi, Shahbazi, Aslani, &amp; Mohammadnia‐Afrouzi, <xref ref-type="ref" rid="brb31199-bib-0053">2018</xref>). On these grounds, it is plausible that miRNAs networks may also impact the human brain development, leading to possible significant changes in regional cerebral volumes with/out subsequent functional (i.e., cognitive) consequences (Xue, Zhuo, &amp; Shan, <xref ref-type="ref" rid="brb31199-bib-0060">2017</xref>).</p>
<p>Following this suggestion, a quite recent study analyzed the differential expression of miRNome in 82 apparently normal postmortem human brain tissue samples belonging to 18 individual donors and spanning through 19 years of age. By looking at different areas, the study showed differentially expressed miRNAs and miRNAs patterns characterizing the cerebral areas, the cerebellum being the most influenced area compared to the other regions in all the studied intervals (65–252 DE miRNAs; Ziats &amp; Rennert, <xref ref-type="ref" rid="brb31199-bib-0062">2014</xref>). On the other hands, peculiar miRNA signatures seem to characterize the individual lesion load and brain atrophy of MS patients; although none of the identified miRNAs associated with the MRI outcomes survived from the correction for multiple comparisons, they pointed the attention to some miRNAs (miR‐92a‐3p, miR‐142‐5p, miR‐143‐3p, miR‐181c‐3p, miR‐181c‐5p, miR‐375, miR‐486‐5p, and miR‐629‐5p) as candidate surrogate markers for the MS monitoring (Regev et al., <xref ref-type="ref" rid="brb31199-bib-0045">2017</xref>). So far, no evidences have been reported about correlations between miRNAs expressions and in vivo regional brain volumes during MS.</p>
<p>In the present observation, we did identify several significant associations between the expressions of several miRNAs and the volume of few brain regions. With caution due to the limited number of MRI examinations (i.e., we were able to analyze only 12 scans), the most interesting results pointed on the cerebellum cortex, which volume significantly correlated with the expression of four miRNAs (miR‐25‐3p, miR‐125a‐5p, miR‐221‐3p, and miR‐320a), in our view confirming the complex molecular influence of this region compared to other areas (Ziats &amp; Rennert, <xref ref-type="ref" rid="brb31199-bib-0062">2014</xref>). Furthermore, lower volumes of the hippocampus correlated with the higher expression of miR‐182‐5p, already reported dysregulated in the cortex and hippocampus of the animal model of prion disease (Boese et al., <xref ref-type="ref" rid="brb31199-bib-0012">2016</xref>). No gender‐related molecular differences with brain regions were found in the examined PedMS population. A larger sample size will possibly add more information on this interesting issue, together with the possibility to compare the MRI data with a population of age‐matched healthy controls (not allowed for the present investigation by the local Ethics Committee).</p>
<p>The same limitation of sizing concerns the correlations between the regional MRI volumes and the cognitive performances. However, it is worthy to note that most of our significant results were confirmations of published reports. Among the others, we obtained significant correlations between the overall corpus callosum atrophy and both the executive functions and depression (Benedict, Ramasamy, Munschauer, Weinstock‐Guttman, &amp; Zivadinov, <xref ref-type="ref" rid="brb31199-bib-0011">2009</xref>; Johnson‐Markve, Lee, Loring, &amp; Viner, <xref ref-type="ref" rid="brb31199-bib-0030">2011</xref>; van Schependom &amp; Nagels, <xref ref-type="ref" rid="brb31199-bib-0054">2017</xref>), whereas the right occipital lobe volume was found significantly related to the performances obtained at SDMT (Akbar et al., <xref ref-type="ref" rid="brb31199-bib-0002">2016</xref>).</p>
<p>Finally, the computational analysis identified several genes that represent the target of most of the significant miRNAs (see Table <xref ref-type="table" rid="brb31199-tbl-0004">4</xref>). Of interest, some of these genes have been reported implicated in diseases with cognitive impairment, for example, <italic>BRI3, RGS6, DIP2A, ZBTB16, BACE2, SIRBP1, IGF2BP2, FCRL5, RTN3, FAM46A, MCF2L, SPI1,</italic> and <italic>TREM1</italic> in Alzheimer's disease (Abd‐Elrahman, Hamilton, Vasefi, &amp; Ferguson, <xref ref-type="ref" rid="brb31199-bib-0001">2018</xref>; Chung et al., <xref ref-type="ref" rid="brb31199-bib-0015">2015</xref>; Comabella et al., <xref ref-type="ref" rid="brb31199-bib-0016">2016</xref>; Dashinimaev, Artyuhov, Bolshakov, Vorotelyak, &amp; Vasiliev, <xref ref-type="ref" rid="brb31199-bib-0017">2017</xref>; De Jager et al., <xref ref-type="ref" rid="brb31199-bib-0018">2014</xref>; Gaikwad et al., <xref ref-type="ref" rid="brb31199-bib-0023">2009</xref>; Gasparoni et al., <xref ref-type="ref" rid="brb31199-bib-0025">2018</xref>; Matsuda, Matsuda, &amp; D'Adamio, <xref ref-type="ref" rid="brb31199-bib-0038">2009</xref>; Moon et al., <xref ref-type="ref" rid="brb31199-bib-0039">2015</xref>; Replogle et al., <xref ref-type="ref" rid="brb31199-bib-0046">2015</xref>; Schott et al., <xref ref-type="ref" rid="brb31199-bib-0051">2016</xref>; Shi, Ge, He, Hu, &amp; Yan, <xref ref-type="ref" rid="brb31199-bib-0052">2017</xref>); or in clinical conditions characterized by behavioral changes, such as <italic>NTNG2</italic> in cognitive abnormalities associated with defective axonal amygdalar projections (Huang et al., <xref ref-type="ref" rid="brb31199-bib-0029">2014</xref>) or bipolar disorders (Egger et al., <xref ref-type="ref" rid="brb31199-bib-0021">2014</xref>), or <italic>RAB11FIP5, WARS, and HES6</italic> in depression and other mood disorders (Bacaj, Ahmad, Jurado, Malenka, &amp; Sudhof, <xref ref-type="ref" rid="brb31199-bib-0007">2015</xref>; Glubb, Joyce, &amp; Kennedy, <xref ref-type="ref" rid="brb31199-bib-0027">2009</xref>; Musante et al., <xref ref-type="ref" rid="brb31199-bib-0040">2017</xref>). Furthermore, the experimental ablation of <italic>CACNA1H</italic>, a gene already associated with the RR course of MS (Sadovnick et al., <xref ref-type="ref" rid="brb31199-bib-0049">2017</xref>), was able to trigger affective disorders including anxiety and hippocampus‐dependent recognition memories (Gangarossa, Laffray, Bourinet, &amp; Valjent, <xref ref-type="ref" rid="brb31199-bib-0024">2014</xref>).</p>
<p>In vitro validation of the significant target genes will be the next following step of our investigation. In fact, we believe that looking more deeply in this tangled network might represent a valuable strategy for enlightening the molecular background of cognitive dysfunctions in MS, and it would be interesting to evaluate other cognitive diseases of the neurodevelopment in order to investigate the molecular cross talk, if any, between the pathological networks of cognition.</p>
<p>In conclusion, as far as we know, this is the first evaluation exploring the association of miRNAs’ expressions with the cognitive performances of PedMS patients. Although the reported results did not survive the corrections for multiple tests possibly due to the small number of cases, in our view some associations deserve further investigation. Furthermore, the integrated miRNAs/mRNAs analysis enabled us to draw an interesting network of molecular connections, thus enlightening some genes that seem to play the role of functional hubs. If confirmed in larger PedMS populations and compared to a population of adult MS patients, this would be a first step toward the development of individualized therapies targeting the cognitive dysfunctions, as well as for the selection of circulating biomarkers (miRNAs) for monitoring the onset and progression of the neuropsychological changes during the course of the disease.</p>
</sec>
<sec id="brb31199-sec-0018">
<title>CONFLICT OF INTEREST</title>
<p>None declared.</p>
</sec>
</body>
<back>
<ack id="brb31199-sec-0019">
<title>ACKNOWLEDGMENTS</title>
<p>The authors are grateful to the PedMS patients and their families who kindly accepted to be part of the project. We also wish to thank: Dr. Nicola Losito (informatics assistance); Drs. Flavio Licciulli, Sabino Liuni, and Giorgio Grillo (bioinformatics support); Drs. Michele Piccolo and Giuseppe Sabatelli (administrative support), Institute of Biomedical Technologies, Bari Unit, National Research Council; Prof. Franca Dicuonzo (availability of MRI scans), Neuroradiology Unit of the Department of Basic Sciences, Neurosciences and Sense Organs, University of Bari.</p>
</ack>
<ref-list content-type="cited-references" id="brb31199-bibl-0001">
<title>REFERENCES</title>
<ref id="brb31199-bib-0001">
<mixed-citation id="brb31199-cit-0001" publication-type="journal">
<string-name>
<surname>Abd‐Elrahman</surname>, <given-names>K. S.</given-names>
</string-name>, <string-name>
<surname>Hamilton</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Vasefi</surname>, <given-names>M.</given-names>
</string-name>, &amp; <string-name>
<surname>Ferguson</surname>, <given-names>S. S. G.</given-names>
</string-name> (<year>2018</year>). <article-title>Autophagy is increased following either pharmacological or genetic silencing of mGluR5 signaling in Alzheimer’s disease mouse models</article-title>. <source xml:lang="en"/>Molecular Brain, <volume>11</volume>, <fpage>19</fpage>
<pub-id pub-id-type="doi">10.1186/s13041-018-0364-9</pub-id>
<pub-id pub-id-type="pmid">29631635</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0002">
<mixed-citation id="brb31199-cit-0002" publication-type="journal">
<string-name>
<surname>Akbar</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Till</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Sled</surname>, <given-names>J. G.</given-names>
</string-name>, <string-name>
<surname>Binns</surname>, <given-names>M. A.</given-names>
</string-name>, <string-name>
<surname>Doesburg</surname>, <given-names>S. M.</given-names>
</string-name>, <string-name>
<surname>Aubert‐Broche</surname>, <given-names>B.</given-names>
</string-name>, … <string-name>
<surname>Banwell</surname>, <given-names>B.</given-names>
</string-name> (<year>2016</year>). <article-title>Altered resting‐state functional connectivity in cognitively preserved pediatric‐onset MS patients and relationship to structural damage and cognitive performance</article-title>. <source xml:lang="en"/>Multiple Sclerosis Journal, <volume>22</volume>, <fpage>792</fpage>–<lpage>800</lpage>. <pub-id pub-id-type="doi">10.1177/1352458515602336</pub-id>
<pub-id pub-id-type="pmid">26362891</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0003">
<mixed-citation id="brb31199-cit-0003" publication-type="journal">
<string-name>
<surname>Amato</surname>, <given-names>M. P.</given-names>
</string-name>, <string-name>
<surname>Bartolozzi</surname>, <given-names>M. L.</given-names>
</string-name>, <string-name>
<surname>Zipoli</surname>, <given-names>V.</given-names>
</string-name>, <string-name>
<surname>Portaccio</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Mortilla</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Guidi</surname>, <given-names>L.</given-names>
</string-name>, … <string-name>
<surname>De Stefano</surname>, <given-names>N.</given-names>
</string-name> (<year>2004</year>). <article-title>Neocortical volume decrease in relapsing‐remitting MS patients with mild cognitive impairment</article-title>. <source xml:lang="en"/>Neurology, <volume>63</volume>, <fpage>89</fpage>–<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1212/01.WNL.0000129544.79539.D5</pub-id>
<pub-id pub-id-type="pmid">15249616</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0004">
<mixed-citation id="brb31199-cit-0004" publication-type="journal">
<string-name>
<surname>Amato</surname>, <given-names>M. P.</given-names>
</string-name>, <string-name>
<surname>Goretti</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Ghezzi</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Hakiki</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Niccolai</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Lori</surname>, <given-names>S.</given-names>
</string-name>, … <string-name>
<surname>Trojano</surname>, <given-names>M.</given-names>
</string-name> (<year>2014</year>). <article-title>Neuropsychological features in childhood and juvenile multiple sclerosis: Five‐year follow‐up</article-title>. <source xml:lang="en"/>Neurology, <volume>83</volume>, <fpage>1432</fpage>–<lpage>1438</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0000000000000885</pub-id>
<pub-id pub-id-type="pmid">25217060</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0005">
<mixed-citation id="brb31199-cit-0005" publication-type="journal">
<string-name>
<surname>Amato</surname>, <given-names>M. P.</given-names>
</string-name>, <string-name>
<surname>Goretti</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Ghezzi</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Lori</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Zipoli</surname>, <given-names>V.</given-names>
</string-name>, <string-name>
<surname>Moiola</surname>, <given-names>L.</given-names>
</string-name>, … <string-name>
<surname>Trojano</surname>, <given-names>M.</given-names>
</string-name> (<year>2010</year>). <article-title>Cognitive and psychosocial features in childhood and juvenile MS: Two‐year follow‐up</article-title>. <source xml:lang="en"/>Neurology, <volume>75</volume>, <fpage>1134</fpage>–<lpage>1140</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0b013e3181f4d821</pub-id>
<pub-id pub-id-type="pmid">20876467</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0006">
<mixed-citation id="brb31199-cit-0006" publication-type="journal">
<string-name>
<surname>Amato</surname>, <given-names>M. P.</given-names>
</string-name>, <string-name>
<surname>Portaccio</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Goretti</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Zipoli</surname>, <given-names>V.</given-names>
</string-name>, <string-name>
<surname>Battaglini</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Bartolozzi</surname>, <given-names>M. L.</given-names>
</string-name>, … <string-name>
<surname>De Stefano</surname>, <given-names>N.</given-names>
</string-name> (<year>2007</year>). <article-title>Association of neocortical volume changes with cognitive deterioration in relapsing‐remitting multiple sclerosis</article-title>. <source xml:lang="en"/>Archives of Neurology, <volume>64</volume>, <fpage>1157</fpage>–<lpage>1161</lpage>. <pub-id pub-id-type="doi">10.1001/archneur.64.8.1157</pub-id>
<pub-id pub-id-type="pmid">17698706</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0007">
<mixed-citation id="brb31199-cit-0007" publication-type="journal">
<string-name>
<surname>Bacaj</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Ahmad</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Jurado</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Malenka</surname>, <given-names>R. C.</given-names>
</string-name>, &amp; <string-name>
<surname>Sudhof</surname>, <given-names>T. C.</given-names>
</string-name> (<year>2015</year>). <article-title>Synaptic function of Rab11Fip5: Selective requirement for hippocampal long‐term depression</article-title>. <source xml:lang="en"/>Journal of Neuroscience, <volume>35</volume>, <fpage>7460</fpage>–<lpage>7474</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1581-14.2015</pub-id>
<pub-id pub-id-type="pmid">25972173</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0008">
<mixed-citation id="brb31199-cit-0008" publication-type="book">
<string-name>
<surname>Banwell</surname>, <given-names>B. L.</given-names>
</string-name> (<year>2014</year>). <chapter-title>Multiple sclerosis in children</chapter-title> In <person-group person-group-type="editor"><name><surname>Goodin</surname><given-names>D. S.</given-names></name></person-group> (Ed.), <source xml:lang="en"/>Handbook of clinical neurology (pp. <fpage>427</fpage>–<lpage>441</lpage>). <publisher-loc>Amsterdam, The Netherlands</publisher-loc>: <publisher-name>Elsevier</publisher-name>.</mixed-citation>
</ref>
<ref id="brb31199-bib-0009">
<mixed-citation id="brb31199-cit-0009" publication-type="journal">
<string-name>
<surname>Banwell</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Ghezzi</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Bar‐Or</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Mikaeloff</surname>, <given-names>Y.</given-names>
</string-name>, &amp; <string-name>
<surname>Tardieu</surname>, <given-names>M.</given-names>
</string-name> (<year>2007</year>). <article-title>Multiple sclerosis in children: Clinical diagnosis, therapeutic strategies, and future directions</article-title>. <source xml:lang="en"/>The Lancet Neurology, <volume>6</volume>, <fpage>887</fpage>–<lpage>902</lpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(07)70242-9</pub-id>
<pub-id pub-id-type="pmid">17884679</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0010">
<mixed-citation id="brb31199-cit-0010" publication-type="journal">
<string-name>
<surname>Baulina</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Kulakova</surname>, <given-names>O.</given-names>
</string-name>, <string-name>
<surname>Kiselev</surname>, <given-names>I.</given-names>
</string-name>, <string-name>
<surname>Osmak</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Popova</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Boyko</surname>, <given-names>A.</given-names>
</string-name>, &amp; <string-name>
<surname>Favorova</surname>, <given-names>O.</given-names>
</string-name> (<year>2018</year>). <article-title>Immune‐related miRNA expression patterns in peripheral blood mononuclear cells differ in multiple sclerosis relapse and remission</article-title>. <source xml:lang="en"/>Journal of Neuroimmunology, <volume>317</volume>, <fpage>67</fpage>–<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1016/j.jneuroim.2018.01.005</pub-id>
<pub-id pub-id-type="pmid">29325906</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0011">
<mixed-citation id="brb31199-cit-0011" publication-type="journal">
<string-name>
<surname>Benedict</surname>, <given-names>R. H. B.</given-names>
</string-name>, <string-name>
<surname>Ramasamy</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Munschauer</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Weinstock‐Guttman</surname>, <given-names>B.</given-names>
</string-name>, &amp; <string-name>
<surname>Zivadinov</surname>, <given-names>R.</given-names>
</string-name> (<year>2009</year>). <article-title>Memory impairment in multiple sclerosis: Correlation with deep grey matter and mesial temporal atrophy</article-title>. <source xml:lang="en"/>Journal of Neurology, Neurosurgery and Psychiatry, <volume>80</volume>, <fpage>201</fpage>–<lpage>206</lpage>. <pub-id pub-id-type="doi">10.1136/jnnp.2008.148403</pub-id>
</mixed-citation>
</ref>
<ref id="brb31199-bib-0012">
<mixed-citation id="brb31199-cit-0012" publication-type="journal">
<string-name>
<surname>Boese</surname>, <given-names>A. S.</given-names>
</string-name>, <string-name>
<surname>Saba</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Campbell</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Majer</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Medina</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Burton</surname>, <given-names>L.</given-names>
</string-name>, … <string-name>
<surname>Booth</surname>, <given-names>S. A.</given-names>
</string-name> (<year>2016</year>). <article-title>MicroRNA abundance is altered in synaptoneurosomes during prion disease</article-title>. <source xml:lang="en"/>Molecular and Cellular Neuroscience, <volume>71</volume>, <fpage>13</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2015.12.001</pub-id>
<pub-id pub-id-type="pmid">26658803</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0013">
<mixed-citation id="brb31199-cit-0013" publication-type="journal">
<string-name>
<surname>Chitnis</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Glanz</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Jaffin</surname>, <given-names>S.</given-names>
</string-name>, &amp; <string-name>
<surname>Healy</surname>, <given-names>B.</given-names>
</string-name> (<year>2009</year>). <article-title>Demographics of pediatric‐onset multiple sclerosis in an MS center population from the Northeastern United States</article-title>. <source xml:lang="en"/>Multiple Sclerosis Journal, <volume>15</volume>, <fpage>627</fpage>–<lpage>631</lpage>. <pub-id pub-id-type="doi">10.1177/1352458508101933</pub-id>
<pub-id pub-id-type="pmid">19299440</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0015">
<mixed-citation id="brb31199-cit-0015" publication-type="journal">
<string-name>
<surname>Chung</surname>, <given-names>S. J.</given-names>
</string-name>, <string-name>
<surname>Kim</surname>, <given-names>M. J.</given-names>
</string-name>, <string-name>
<surname>Kim</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Ryu</surname>, <given-names>H. S.</given-names>
</string-name>, <string-name>
<surname>Kim</surname>, <given-names>Y. J.</given-names>
</string-name>, <string-name>
<surname>Kim</surname>, <given-names>S. Y.</given-names>
</string-name>, &amp; <string-name>
<surname>Lee</surname>, <given-names>J. H.</given-names>
</string-name> (<year>2015</year>). <article-title>Association of type 2 diabetes GWAS loci and the risk of Parkinson’s and Alzheimer’s diseases</article-title>. <source xml:lang="en"/>Parkinsonism and Related Disorders, <volume>21</volume>, <fpage>1435</fpage>–<lpage>1450</lpage>. <pub-id pub-id-type="doi">10.1016/j.parkreldis.2015.10.010</pub-id>
<pub-id pub-id-type="pmid">26499758</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0016">
<mixed-citation id="brb31199-cit-0016" publication-type="journal">
<string-name>
<surname>Comabella</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Cantó</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Nurtdinov</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Río</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Villar</surname>, <given-names>L. M.</given-names>
</string-name>, <string-name>
<surname>Picón</surname>, <given-names>C.</given-names>
</string-name>, … <string-name>
<surname>Montalban</surname>, <given-names>X.</given-names>
</string-name> (<year>2016</year>). <article-title>MRI phenotypes with high neurodegeneration are associated with peripheral blood B‐cell changes</article-title>. <source xml:lang="en"/>Human Molecular Genetics, <volume>25</volume>, <fpage>308</fpage>–<lpage>316</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddv473</pub-id>
<pub-id pub-id-type="pmid">26604134</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0017">
<mixed-citation id="brb31199-cit-0017" publication-type="journal">
<string-name>
<surname>Dashinimaev</surname>, <given-names>E. B.</given-names>
</string-name>, <string-name>
<surname>Artyuhov</surname>, <given-names>A. S.</given-names>
</string-name>, <string-name>
<surname>Bolshakov</surname>, <given-names>A. P.</given-names>
</string-name>, <string-name>
<surname>Vorotelyak</surname>, <given-names>E. A.</given-names>
</string-name>, &amp; <string-name>
<surname>Vasiliev</surname>, <given-names>A. V.</given-names>
</string-name> (<year>2017</year>). <article-title>Neurons derived from induced pluripotent stem cells of patients with down syndrome reproduce early stages of alzheimer’s disease type pathology in vitro</article-title>. <source xml:lang="en"/>Journal of Alzheimer's Disease, <volume>56</volume>, <fpage>835</fpage>–<lpage>847</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-160945</pub-id>
</mixed-citation>
</ref>
<ref id="brb31199-bib-0018">
<mixed-citation id="brb31199-cit-0018" publication-type="journal">
<string-name>
<surname>De Jager</surname>, <given-names>P. L.</given-names>
</string-name>, <string-name>
<surname>Srivastava</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Lunnon</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Burgess</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Schalkwyk</surname>, <given-names>L. C.</given-names>
</string-name>, <string-name>
<surname>Yu</surname>, <given-names>L.</given-names>
</string-name>, … <string-name>
<surname>Bennett</surname>, <given-names>D. A.</given-names>
</string-name> (<year>2014</year>). <article-title>Alzheimer’s disease: Early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci</article-title>. <source xml:lang="en"/>Nature Neuroscience, <volume>17</volume>, <fpage>1156</fpage>–<lpage>1163</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3786</pub-id>
<pub-id pub-id-type="pmid">25129075</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0019">
<mixed-citation id="brb31199-cit-0019" publication-type="journal">
<string-name>
<surname>Di Filippo</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Portaccio</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Mancini</surname>, <given-names>A.</given-names>
</string-name>, &amp; <string-name>
<surname>Calabresi</surname>, <given-names>P.</given-names>
</string-name> (<year>2018</year>). <article-title>Dysfunction</article-title>. <source xml:lang="en"/>Nature Reviews in Neurosciences, <volume>19</volume>, <fpage>599</fpage>–<lpage>609</lpage>.</mixed-citation>
</ref>
<ref id="brb31199-bib-0020">
<mixed-citation id="brb31199-cit-0020" publication-type="journal">
<string-name>
<surname>Dutta</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Chomyk</surname>, <given-names>A. M.</given-names>
</string-name>, <string-name>
<surname>Chang</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Ribaudo</surname>, <given-names>M. V.</given-names>
</string-name>, <string-name>
<surname>Deckard</surname>, <given-names>S. A.</given-names>
</string-name>, <string-name>
<surname>Doud</surname>, <given-names>M. K.</given-names>
</string-name>, … <string-name>
<surname>Trapp</surname>, <given-names>B. D.</given-names>
</string-name> (<year>2013</year>). <article-title>Hippocampal demyelination and memory dysfunction are associated with increased levels of the neuronal microRNA miR‐124 and reduced AMPA receptors</article-title>. <source xml:lang="en"/>Annals of Neurology, <volume>73</volume>, <fpage>637</fpage>–<lpage>645</lpage>. <pub-id pub-id-type="doi">10.1002/ana.23860</pub-id>
<pub-id pub-id-type="pmid">23595422</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0021">
<mixed-citation id="brb31199-cit-0021" publication-type="journal">
<string-name>
<surname>Egger</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Roetzer</surname>, <given-names>K. M.</given-names>
</string-name>, <string-name>
<surname>Noor</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Lionel</surname>, <given-names>A. C.</given-names>
</string-name>, <string-name>
<surname>Mahmood</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Schwarzbraun</surname>, <given-names>T.</given-names>
</string-name>, … <string-name>
<surname>Vincent</surname>, <given-names>J. B.</given-names>
</string-name> (<year>2014</year>). <article-title>Identification of risk genes for autism spectrum disorder through copy number variation analysis in Austrian families</article-title>. <source xml:lang="en"/>Neurogenetics, <volume>15</volume>, <fpage>117</fpage>–<lpage>127</lpage>. <pub-id pub-id-type="doi">10.1007/s10048-014-0394-0</pub-id>
<pub-id pub-id-type="pmid">24643514</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0022">
<mixed-citation id="brb31199-cit-0022" publication-type="journal">
<string-name>
<surname>Fenoglio</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>De Riz</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Pietroboni</surname>, <given-names>A. M.</given-names>
</string-name>, <string-name>
<surname>Calvi</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Serpente</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Cioffi</surname>, <given-names>S. M. G.</given-names>
</string-name>, … <string-name>
<surname>Galimberti</surname>, <given-names>D.</given-names>
</string-name> (<year>2016</year>). <article-title>Effect of fingolimod treatment on circulating miR‐15b, miR23a and miR‐223 levels in patients with multiple sclerosis</article-title>. <source xml:lang="en"/>Journal of Neuroimmunology, <volume>15</volume>, <fpage>81</fpage>–<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1016/j.jneuroim.2016.08.017</pub-id>
</mixed-citation>
</ref>
<ref id="brb31199-bib-0023">
<mixed-citation id="brb31199-cit-0023" publication-type="journal">
<string-name>
<surname>Gaikwad</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Larionov</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Wang</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Dannenberg</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Matozaki</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Monsonego</surname>, <given-names>A.</given-names>
</string-name>, … <string-name>
<surname>Neumann</surname>, <given-names>H.</given-names>
</string-name> (<year>2009</year>). <article-title>Signal regulatory protein‐β1: A microglial modulator of phagocytosis in Alzheimer’s disease</article-title>. <source xml:lang="en"/>The American Journal of Pathology, <volume>175</volume>, <fpage>2528</fpage>–<lpage>2539</lpage>. <pub-id pub-id-type="doi">10.2353/ajpath.2009.090147</pub-id>
<pub-id pub-id-type="pmid">19893026</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0024">
<mixed-citation id="brb31199-cit-0024" publication-type="journal">
<string-name>
<surname>Gangarossa</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Laffray</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Bourinet</surname>, <given-names>E.</given-names>
</string-name>, &amp; <string-name>
<surname>Valjent</surname>, <given-names>E.</given-names>
</string-name> (<year>2014</year>). <article-title>T‐type calcium channel Cav3.2 deficient mice show elevated anxiety, impaired memory and reduced sensitivity to psychostimulants</article-title>. <source xml:lang="en"/>Frontiers in Behavioral Neuroscience, <volume>8</volume>, <fpage>92</fpage>
<pub-id pub-id-type="doi">10.3389/fnbeh.2014.00092</pub-id>
<pub-id pub-id-type="pmid">24672455</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0025">
<mixed-citation id="brb31199-cit-0025" publication-type="journal">
<string-name>
<surname>Gasparoni</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Bultmann</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Lutsik</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Kraus</surname>, <given-names>T. F. J.</given-names>
</string-name>, <string-name>
<surname>Sordon</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Vlcek</surname>, <given-names>J.</given-names>
</string-name>, … <string-name>
<surname>Walter</surname>, <given-names>J.</given-names>
</string-name> (<year>2018</year>). <article-title>DNA methylation analysis on purified neurons and glia dissects age and Alzheimer’s disease‐specific changes in the human cortex</article-title>. <source xml:lang="en"/>Epigenetics and Chromatin, <volume>11</volume>, <fpage>41</fpage>
<pub-id pub-id-type="doi">10.1186/s13072-018-0211-3</pub-id>
<pub-id pub-id-type="pmid">30045751</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0026">
<mixed-citation id="brb31199-cit-0026" publication-type="journal">
<string-name>
<surname>Ghezzi</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Goretti</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Portaccio</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Roscio</surname>, <given-names>M.</given-names>
</string-name>, &amp; <string-name>
<surname>Amato</surname>, <given-names>M. P.</given-names>
</string-name> (<year>2010</year>). <article-title>Cognitive impairment in pediatric multiple sclerosis</article-title>. <source xml:lang="en"/>Neurological Sciences, <volume>31</volume>, <fpage>S215</fpage>–<lpage>218</lpage>. <pub-id pub-id-type="doi">10.1007/s10072-010-0437-8</pub-id>
<pub-id pub-id-type="pmid">20938701</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0027">
<mixed-citation id="brb31199-cit-0027" publication-type="journal">
<string-name>
<surname>Glubb</surname>, <given-names>D. M.</given-names>
</string-name>, <string-name>
<surname>Joyce</surname>, <given-names>P. R.</given-names>
</string-name>, &amp; <string-name>
<surname>Kennedy</surname>, <given-names>M. A.</given-names>
</string-name> (<year>2009</year>). <article-title>Expression and association analyses of promoter variants of the neurogenic gene HES6, a candidate gene for mood disorder susceptibility and antidepressant response</article-title>. <source xml:lang="en"/>Neuroscience Letters, <volume>460</volume>, <fpage>185</fpage>–<lpage>190</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2009.05.065</pub-id>
<pub-id pub-id-type="pmid">19481584</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0028">
<mixed-citation id="brb31199-cit-0028" publication-type="journal">
<string-name>
<surname>Goretti</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Portaccio</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Ghezzi</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Lori</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Moiola</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Falautano</surname>, <given-names>M.</given-names>
</string-name>, … <string-name>
<surname>Amato</surname>, <given-names>M. P.</given-names>
</string-name> (<year>2012</year>). <article-title>Fatigue and its relationships with cognitive functioning and depression in paediatric multiple sclerosis</article-title>. <source xml:lang="en"/>Multiple Sclerosis Journal, <volume>18</volume>, <fpage>329</fpage>–<lpage>334</lpage>. <pub-id pub-id-type="doi">10.1177/1352458511420846</pub-id>
<pub-id pub-id-type="pmid">21844064</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0029">
<mixed-citation id="brb31199-cit-0029" publication-type="journal">
<string-name>
<surname>Huang</surname>, <given-names>T. N.</given-names>
</string-name>, <string-name>
<surname>Chuang</surname>, <given-names>H. C.</given-names>
</string-name>, <string-name>
<surname>Chou</surname>, <given-names>W. H.</given-names>
</string-name>, <string-name>
<surname>Chen</surname>, <given-names>C. Y.</given-names>
</string-name>, <string-name>
<surname>Wang</surname>, <given-names>H. F.</given-names>
</string-name>, <string-name>
<surname>Chou</surname>, <given-names>S. J.</given-names>
</string-name>, &amp; <string-name>
<surname>Hsueh</surname>, <given-names>Y. P.</given-names>
</string-name> (<year>2014</year>). <article-title>Tbr1 haploinsufficiency impairs amygdalar axonal projections and results in cognitive abnormality</article-title>. <source xml:lang="en"/>Nature Neuroscience, <volume>17</volume>, <fpage>240</fpage>–<lpage>247</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3626</pub-id>
<pub-id pub-id-type="pmid">24441682</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0030">
<mixed-citation id="brb31199-cit-0030" publication-type="journal">
<string-name>
<surname>Johnson‐Markve</surname>, <given-names>B. L.</given-names>
</string-name>, <string-name>
<surname>Lee</surname>, <given-names>G. P.</given-names>
</string-name>, <string-name>
<surname>Loring</surname>, <given-names>D. W.</given-names>
</string-name>, &amp; <string-name>
<surname>Viner</surname>, <given-names>K. M.</given-names>
</string-name> (<year>2011</year>). <article-title>Usefulness of verbal selective reminding in distinguishing frontal lobe memory disorders in epilepsy</article-title>. <source xml:lang="en"/>Epilepsy and Behavior, <volume>22</volume>, <fpage>313</fpage>–<lpage>317</lpage>. <pub-id pub-id-type="doi">10.1016/j.yebeh.2011.06.039</pub-id>
<pub-id pub-id-type="pmid">21855419</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0031">
<mixed-citation id="brb31199-cit-0031" publication-type="journal">
<string-name>
<surname>Julian</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Serafin</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Charvet</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Ackerson</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Benedict</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Braaten</surname>, <given-names>E.</given-names>
</string-name>, … <string-name>
<surname>Krupp</surname>, <given-names>L. B.</given-names>
</string-name> (<year>2013</year>). <article-title>Cognitive impairment occurs in children and adolescents with multiple sclerosis: Results from a United States network</article-title>. <source xml:lang="en"/>Journal of Child Neurology, <volume>28</volume>, <fpage>102</fpage>–<lpage>107</lpage>. <pub-id pub-id-type="doi">10.1177/0883073812464816</pub-id>
<pub-id pub-id-type="pmid">23155206</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0032">
<mixed-citation id="brb31199-cit-0032" publication-type="journal">
<string-name>
<surname>Keller</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Leidinger</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Bauer</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Elsharawy</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Haas</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Backes</surname>, <given-names>C.</given-names>
</string-name>, … <string-name>
<surname>Meese</surname>, <given-names>E.</given-names>
</string-name> (<year>2011</year>). <article-title>Toward the blood‐borne miRNome of human diseases</article-title>. <source xml:lang="en"/>Nature Methods, <volume>8</volume>, <fpage>841</fpage>–<lpage>843</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.1682</pub-id>
<pub-id pub-id-type="pmid">21892151</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0033">
<mixed-citation id="brb31199-cit-0033" publication-type="journal">
<string-name>
<surname>Konrad</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Firk</surname>, <given-names>C.</given-names>
</string-name>, &amp; <string-name>
<surname>Uhlhaas</surname>, <given-names>P. J.</given-names>
</string-name> (<year>2013</year>). <article-title>Brain development during adolescence: Neuroscientific insights into this developmental period</article-title>. <source xml:lang="en"/>Deutsches Ärzteblatt International, <volume>110</volume>, <fpage>425</fpage>–<lpage>431</lpage>.<pub-id pub-id-type="pmid">23840287</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0034">
<mixed-citation id="brb31199-cit-0034" publication-type="journal">
<string-name>
<surname>Kos</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Olde Loohuis</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Meinhardt</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>van Bokhoven</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Kaplan</surname>, <given-names>B. B.</given-names>
</string-name>, <string-name>
<surname>Martens</surname>, <given-names>G. J.</given-names>
</string-name>, &amp; <string-name>
<surname>Aschrafi</surname>, <given-names>A.</given-names>
</string-name> (<year>2016</year>). <article-title>MicroRNA‐181 promotes synaptogenesis and attenuates axonal outgrowth in cortical neurons</article-title>. <source xml:lang="en"/>Cellular and Molecular Life Sciences, <volume>73</volume>, <fpage>637</fpage>–<lpage>645</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-016-2179-0</pub-id>
<pub-id pub-id-type="pmid">26265182</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0035">
<mixed-citation id="brb31199-cit-0035" publication-type="journal">
<string-name>
<surname>Kurtzke</surname>, <given-names>J. F.</given-names>
</string-name> (<year>1983</year>). <article-title>Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)</article-title>. <source xml:lang="en"/>Neurology, <volume>33</volume>, <fpage>1444</fpage>–<lpage>1452</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.33.11.1444</pub-id>
<pub-id pub-id-type="pmid">6685237</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0036">
<mixed-citation id="brb31199-cit-0036" publication-type="journal">
<string-name>
<surname>Liguori</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Nuzziello</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Introna</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Consiglio</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Licciulli</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>D’Errico</surname>, <given-names>E.</given-names>
</string-name>, … <string-name>
<surname>Simone</surname>, <given-names>I. L.</given-names>
</string-name> (<year>2018a</year>). <article-title>Dysregulation of MicroRNAs and target genes networks in peripheral blood of patients with sporadic amyotrophic lateral sclerosis</article-title>. <source xml:lang="en"/>Frontiers in Molecular Neuroscience, <volume>11</volume>, <fpage>1</fpage>–<lpage>16</lpage>.<pub-id pub-id-type="pmid">29403353</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0037">
<mixed-citation id="brb31199-cit-0037" publication-type="journal">
<string-name>
<surname>Liguori</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Nuzziello</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Licciulli</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Consiglio</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Simone</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Viterbo</surname>, <given-names>R. G.</given-names>
</string-name>, … <string-name>
<surname>Trojano</surname>, <given-names>M.</given-names>
</string-name> (<year>2018b</year>). <article-title>Combined microRNA and mRNA expression analysis in pediatric multiple sclerosis: An integrated approach to uncover novel pathogenic mechanisms of the disease</article-title>. <source xml:lang="en"/>Human Molecular Genetics, <volume>27</volume>(<issue>27</issue>), <fpage>66</fpage>–<lpage>79</lpage>.<pub-id pub-id-type="pmid">29087462</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0038">
<mixed-citation id="brb31199-cit-0038" publication-type="journal">
<string-name>
<surname>Matsuda</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Matsuda</surname>, <given-names>Y.</given-names>
</string-name>, &amp; <string-name>
<surname>D’Adamio</surname>, <given-names>L.</given-names>
</string-name> (<year>2009</year>). <article-title>BRI3 inhibits amyloid precursor protein processing in a mechanistically distinct manner from its homologue Dementia gene BRI2</article-title>. <source xml:lang="en"/>Journal of Biological Chemistry, <volume>284</volume>, <fpage>15815</fpage>–<lpage>15825</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M109.006403</pub-id>
<pub-id pub-id-type="pmid">19366692</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0039">
<mixed-citation id="brb31199-cit-0039" publication-type="journal">
<string-name>
<surname>Moon</surname>, <given-names>S. W.</given-names>
</string-name>, <string-name>
<surname>Dinov</surname>, <given-names>I. D.</given-names>
</string-name>, <string-name>
<surname>Kim</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Zamanyan</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Hobel</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Thompson</surname>, <given-names>P. M.</given-names>
</string-name>, &amp; <string-name>
<surname>Toga</surname>, <given-names>A. W.</given-names>
</string-name> (<year>2015</year>). <article-title>Structural neuroimaging genetics interactions in Alzheimer’s disease</article-title>. <source xml:lang="en"/>Journal of Alzheimer's Disease, <volume>48</volume>, <fpage>125</fpage>–<lpage>135</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-150335</pub-id>
</mixed-citation>
</ref>
<ref id="brb31199-bib-0040">
<mixed-citation id="brb31199-cit-0040" publication-type="journal">
<string-name>
<surname>Musante</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Püttmann</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Kahrizi</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Garshasbi</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Hu</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Stehr</surname>, <given-names>H.</given-names>
</string-name>, … <string-name>
<surname>Kuss</surname>, <given-names>A. W.</given-names>
</string-name> (<year>2017</year>). <article-title>Mutations of the aminoacyl‐tRNA‐synthetases SARS and WARS2 are implicated in the etiology of autosomal recessive intellectual disability</article-title>. <source xml:lang="en"/>Human Mutation, <volume>38</volume>, <fpage>621</fpage>–<lpage>636</lpage>. <pub-id pub-id-type="doi">10.1002/humu.23205</pub-id>
<pub-id pub-id-type="pmid">28236339</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0041">
<mixed-citation id="brb31199-cit-0041" publication-type="journal">
<string-name>
<surname>Niwald</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Migdalska‐Sęk</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Brzeziańska‐Lasota</surname>, <given-names>E.</given-names>
</string-name>, &amp; <string-name>
<surname>Miller</surname>, <given-names>E.</given-names>
</string-name> (<year>2017</year>). <article-title>Evaluation of selected MicroRNAs expression in remission phase of multiple sclerosis and their potential link to cognition, depression, and disability</article-title>. <source xml:lang="en"/>Journal of Molecular Neuroscience, <volume>63</volume>, <fpage>275</fpage>–<lpage>282</lpage>. <pub-id pub-id-type="doi">10.1007/s12031-017-0977-y</pub-id>
<pub-id pub-id-type="pmid">29043654</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0042">
<mixed-citation id="brb31199-cit-0042" publication-type="journal">
<string-name>
<surname>Nunan‐Saah</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Paulraj</surname>, <given-names>S. R.</given-names>
</string-name>, <string-name>
<surname>Waubant</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Krupp</surname>, <given-names>L. B.</given-names>
</string-name>, &amp; <string-name>
<surname>Gomez</surname>, <given-names>R. G.</given-names>
</string-name> (<year>2015</year>). <article-title>Neuropsychological correlates of multiple sclerosis across the lifespan</article-title>. <source xml:lang="en"/>Multiple Sclerosis Journal, <volume>21</volume>, <fpage>1355</fpage>–<lpage>1364</lpage>. <pub-id pub-id-type="doi">10.1177/1352458515586088</pub-id>
<pub-id pub-id-type="pmid">26163074</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0043">
<mixed-citation id="brb31199-cit-0043" publication-type="journal">
<string-name>
<surname>Olde Loohuis</surname>, <given-names>N. F. M.</given-names>
</string-name>, <string-name>
<surname>Kos</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Martens</surname>, <given-names>G. J. M.</given-names>
</string-name>, <string-name>
<surname>Van Bokhoven</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Nadif Kasri</surname>, <given-names>N.</given-names>
</string-name>, &amp; <string-name>
<surname>Aschrafi</surname>, <given-names>A.</given-names>
</string-name> (<year>2012</year>). <article-title>MicroRNA networks direct neuronal development and plasticity</article-title>. <source xml:lang="en"/>Cellular and Molecular Life Sciences, <volume>69</volume>, <fpage>89</fpage>–<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-011-0788-1</pub-id>
<pub-id pub-id-type="pmid">21833581</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0044">
<mixed-citation id="brb31199-cit-0044" publication-type="journal">
<string-name>
<surname>Olsson</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Barcellos</surname>, <given-names>L. F.</given-names>
</string-name>, &amp; <string-name>
<surname>Alfredsson</surname>, <given-names>L.</given-names>
</string-name> (<year>2016</year>). <article-title>Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis</article-title>. <source xml:lang="en"/>Nature Reviews Neurology, <volume>13</volume>, <fpage>25</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1038/nrneurol.2016.187</pub-id>
<pub-id pub-id-type="pmid">27934854</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0045">
<mixed-citation id="brb31199-cit-0045" publication-type="journal">
<string-name>
<surname>Regev</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Healy</surname>, <given-names>B. C.</given-names>
</string-name>, <string-name>
<surname>Khalid</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Paul</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Chu</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Tauhid</surname>, <given-names>S.</given-names>
</string-name>, … <string-name>
<surname>Bakshi</surname>, <given-names>R.</given-names>
</string-name> (<year>2017</year>). <article-title>Association between serum MicroRNAs and magnetic resonance imaging measures of multiple sclerosis severity</article-title>. <source xml:lang="en"/>JAMA Neurology, <volume>74</volume>, <fpage>275</fpage>–<lpage>285</lpage>. <pub-id pub-id-type="doi">10.1001/jamaneurol.2016.5197</pub-id>
<pub-id pub-id-type="pmid">28114622</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0046">
<mixed-citation id="brb31199-cit-0046" publication-type="journal">
<string-name>
<surname>Replogle</surname>, <given-names>J. M.</given-names>
</string-name>, <string-name>
<surname>Chan</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>White</surname>, <given-names>C. C.</given-names>
</string-name>, <string-name>
<surname>Raj</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Winn</surname>, <given-names>P. A.</given-names>
</string-name>, <string-name>
<surname>Evans</surname>, <given-names>D. A.</given-names>
</string-name>, … <string-name>
<surname>De Jager</surname>, <given-names>P. L.</given-names>
</string-name> (<year>2015</year>). <article-title>A TREM1 variant alters the accumulation of alzheimer‐related amyloid pathology</article-title>. <source xml:lang="en"/>Annals of Neurology, <volume>77</volume>, <fpage>469</fpage>–<lpage>477</lpage>.<pub-id pub-id-type="pmid">25545807</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0047">
<mixed-citation id="brb31199-cit-0047" publication-type="journal">
<string-name>
<surname>Rocca</surname>, <given-names>M. A.</given-names>
</string-name>, <string-name>
<surname>Absinta</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Amato</surname>, <given-names>M. P.</given-names>
</string-name>, <string-name>
<surname>Moiola</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Ghezzi</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Veggiotti</surname>, <given-names>P.</given-names>
</string-name>, … <string-name>
<surname>Filippi</surname>, <given-names>M.</given-names>
</string-name> (<year>2014</year>). <article-title>Posterior brain damage and cognitive impairment in pediatric multiple sclerosis</article-title>. <source xml:lang="en"/>Neurology, <volume>82</volume>, <fpage>1314</fpage>–<lpage>1321</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0000000000000309</pub-id>
<pub-id pub-id-type="pmid">24647027</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0048">
<mixed-citation id="brb31199-cit-0048" publication-type="journal">
<string-name>
<surname>Saab</surname>, <given-names>B. J.</given-names>
</string-name>, &amp; <string-name>
<surname>Mansuy</surname>, <given-names>I. M.</given-names>
</string-name> (<year>2014</year>). <article-title>Neuroepigenetics of memory formation and impairment: The role of microRNAs</article-title>. <source xml:lang="en"/>Neuropharmacology, <volume>80</volume>, <fpage>61</fpage>–<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2014.01.026</pub-id>
<pub-id pub-id-type="pmid">24486712</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0049">
<mixed-citation id="brb31199-cit-0049" publication-type="journal">
<string-name>
<surname>Sadovnick</surname>, <given-names>A. D.</given-names>
</string-name>, <string-name>
<surname>Traboulsee</surname>, <given-names>A. L.</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Bernales</surname>, <given-names>C. Q.</given-names>
</string-name>, <string-name>
<surname>Encarnacion</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Ross</surname>, <given-names>J. P.</given-names>
</string-name>, … <string-name>
<surname>Vilariño‐Güell</surname>, <given-names>C.</given-names>
</string-name> (<year>2017</year>). <article-title>Genetic modifiers of multiple sclerosis progression, severity and onset</article-title>. <source xml:lang="en"/>Clinical Immunology, <volume>180</volume>, <fpage>100</fpage>–<lpage>105</lpage>. <pub-id pub-id-type="doi">10.1016/j.clim.2017.05.009</pub-id>
<pub-id pub-id-type="pmid">28501589</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0050">
<mixed-citation id="brb31199-cit-0050" publication-type="journal">
<string-name>
<surname>Sáenz‐Cuesta</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Alberro</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Muñoz‐culla</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Osorio‐Querejeta</surname>, <given-names>I.</given-names>
</string-name>, <string-name>
<surname>Id</surname>, <given-names>M. F.</given-names>
</string-name>, <string-name>
<surname>Lopetegui</surname>, <given-names>I.</given-names>
</string-name>, … <string-name>
<surname>Otaegui</surname>, <given-names>D.</given-names>
</string-name> (<year>2018</year>). <article-title>The first dose of fingolimod affects circulating extracellular vesicles in multiple sclerosis patients</article-title>. <source xml:lang="en"/>International Journal of Molecular Sciences, <volume>19</volume>, <fpage>19</fpage>
<pub-id pub-id-type="doi">10.3390/ijms19082448</pub-id>
</mixed-citation>
</ref>
<ref id="brb31199-bib-0051">
<mixed-citation id="brb31199-cit-0051" publication-type="journal">
<string-name>
<surname>Schott</surname>, <given-names>J. M.</given-names>
</string-name>, <string-name>
<surname>Crutch</surname>, <given-names>S. J.</given-names>
</string-name>, <string-name>
<surname>Carrasquillo</surname>, <given-names>M. M.</given-names>
</string-name>, <string-name>
<surname>Uphill</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Shakespeare</surname>, <given-names>T. J.</given-names>
</string-name>, <string-name>
<surname>Ryan</surname>, <given-names>N. S.</given-names>
</string-name>, … <string-name>
<surname>Mead</surname>, <given-names>S.</given-names>
</string-name> (<year>2016</year>). <article-title>Genetic risk factors for the posterior cortical atrophy variant of Alzheimer’s disease</article-title>. <source xml:lang="en"/>Alzheimer's and Dementia, <volume>12</volume>, <fpage>862</fpage>–<lpage>871</lpage>. <pub-id pub-id-type="doi">10.1016/j.jalz.2016.01.010</pub-id>
</mixed-citation>
</ref>
<ref id="brb31199-bib-0052">
<mixed-citation id="brb31199-cit-0052" publication-type="journal">
<string-name>
<surname>Shi</surname>, <given-names>Q.</given-names>
</string-name>, <string-name>
<surname>Ge</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>He</surname>, <given-names>W.</given-names>
</string-name>, <string-name>
<surname>Hu</surname>, <given-names>X.</given-names>
</string-name>, &amp; <string-name>
<surname>Yan</surname>, <given-names>R.</given-names>
</string-name> (<year>2017</year>). <article-title>RTN1 and RTN3 protein are differentially associated with senile plaques in Alzheimer’s brains</article-title>. <source xml:lang="en"/>Scientific Reports, <volume>7</volume>, <fpage>6145</fpage>
<pub-id pub-id-type="doi">10.1038/s41598-017-05504-9</pub-id>
<pub-id pub-id-type="pmid">28733667</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0053">
<mixed-citation id="brb31199-cit-0053" publication-type="journal">
<string-name>
<surname>Soltanzadeh‐Yamchi</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Shahbazi</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Aslani</surname>, <given-names>S.</given-names>
</string-name>, &amp; <string-name>
<surname>Mohammadnia‐Afrouzi</surname>, <given-names>M.</given-names>
</string-name> (<year>2018</year>). <article-title>MicroRNA signature of regulatory T cells in health and autoimmunity</article-title>. <source xml:lang="en"/>Biomedicine and Pharmacotherapy, <volume>100</volume>, <fpage>316</fpage>–<lpage>323</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2018.02.030</pub-id>
<pub-id pub-id-type="pmid">29453041</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0054">
<mixed-citation id="brb31199-cit-0054" publication-type="journal">
<string-name>
<surname>van Schependom</surname>, <given-names>J.</given-names>
</string-name>, &amp; <string-name>
<surname>Nagels</surname>, <given-names>G.</given-names>
</string-name> (<year>2017</year>). <article-title>Targeting cognitive impairment in multiple sclerosis‐the road toward an imaging‐based biomarker</article-title>. <source xml:lang="en"/>Frontiers in Neuroscience, <volume>40</volume>, <fpage>109</fpage>–<lpage>114</lpage>.</mixed-citation>
</ref>
<ref id="brb31199-bib-0055">
<mixed-citation id="brb31199-cit-0055" publication-type="journal">
<string-name>
<surname>Vistbakka</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Sumelahti</surname>, <given-names>M. L.</given-names>
</string-name>, <string-name>
<surname>Lehtimäki</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Elovaara</surname>, <given-names>I.</given-names>
</string-name>, &amp; <string-name>
<surname>Hagman</surname>, <given-names>S.</given-names>
</string-name> (<year>2018</year>). <article-title>Evaluation of serum miR‐191‐5p, miR‐24‐3p, miR‐128‐3p, and miR‐376c‐3 in multiple sclerosis patients</article-title>. <source xml:lang="en"/>Acta Neurologica Scandinavica, <volume>138</volume>, <fpage>130</fpage>–<lpage>136</lpage>. <pub-id pub-id-type="doi">10.1111/ane.12921</pub-id>
<pub-id pub-id-type="pmid">29527713</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0056">
<mixed-citation id="brb31199-cit-0056" publication-type="journal">
<string-name>
<surname>Waldman</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Ness</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Pohl</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Simone</surname>, <given-names>I. L.</given-names>
</string-name>, <string-name>
<surname>Anlar</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Amato</surname>, <given-names>M. P.</given-names>
</string-name>, &amp; <string-name>
<surname>Ghezzi</surname>, <given-names>A.</given-names>
</string-name> (<year>2016</year>). <article-title>Pediatric multiple sclerosis clinical features and outcome</article-title>. <source xml:lang="en"/>Neurology. <volume>87</volume>(<issue>9 Suppl 2</issue>), <fpage>S74</fpage>–<lpage>S81</lpage>.<pub-id pub-id-type="pmid">27572865</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0057">
<mixed-citation id="brb31199-cit-0057" publication-type="journal">
<string-name>
<surname>Waubant</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Chabas</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Okuda</surname>, <given-names>D. T.</given-names>
</string-name>, <string-name>
<surname>Glenn</surname>, <given-names>O.</given-names>
</string-name>, <string-name>
<surname>Mowry</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Henry</surname>, <given-names>R. G.</given-names>
</string-name>, … <string-name>
<surname>Pelletier</surname>, <given-names>D.</given-names>
</string-name> (<year>2009</year>). <article-title>Difference in disease burden and activity in pediatric patients on brain magnetic resonance imaging at time of multiple sclerosis onset vs adults</article-title>. <source xml:lang="en"/>Archives of Neurology, <volume>66</volume>, <fpage>967</fpage>–<lpage>971</lpage>. <pub-id pub-id-type="doi">10.1001/archneurol.2009.135</pub-id>
<pub-id pub-id-type="pmid">19667217</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0058">
<mixed-citation id="brb31199-cit-0058" publication-type="journal">
<string-name>
<surname>Woldemichael</surname>, <given-names>B. T.</given-names>
</string-name>, &amp; <string-name>
<surname>Mansuy</surname>, <given-names>I. M.</given-names>
</string-name> (<year>2016</year>). <article-title>Micro‐RNAs in cognition and cognitive disorders: Potential for novel biomarkers and therapeutics</article-title>. <source xml:lang="en"/>Biochemical Pharmacology, <volume>104</volume>, <fpage>1</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.bcp.2015.11.021</pub-id>
<pub-id pub-id-type="pmid">26626188</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0059">
<mixed-citation id="brb31199-cit-0059" publication-type="journal">
<string-name>
<surname>Xu</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Hsu</surname>, <given-names>P. K.</given-names>
</string-name>, <string-name>
<surname>Karayiorgou</surname>, <given-names>M.</given-names>
</string-name>, &amp; <string-name>
<surname>Gogos</surname>, <given-names>J. A.</given-names>
</string-name> (<year>2012</year>). <article-title>MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction</article-title>. <source xml:lang="en"/>Neurobiology of Disease, <volume>46</volume>, <fpage>291</fpage>–<lpage>301</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2012.02.016</pub-id>
<pub-id pub-id-type="pmid">22406400</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0060">
<mixed-citation id="brb31199-cit-0060" publication-type="journal">
<string-name>
<surname>Xue</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Zhuo</surname>, <given-names>Y.</given-names>
</string-name>, &amp; <string-name>
<surname>Shan</surname>, <given-names>B.</given-names>
</string-name> (<year>2017</year>). <article-title>MicroRNAs, long noncoding RNAs, and their functions in human disease</article-title>. <source xml:lang="en"/>Methods in Molecular Biology, <volume>1617</volume>, <fpage>1</fpage>–<lpage>25</lpage>.<pub-id pub-id-type="pmid">28540673</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0061">
<mixed-citation id="brb31199-cit-0061" publication-type="journal">
<string-name>
<surname>Zhang</surname>, <given-names>S. F.</given-names>
</string-name>, <string-name>
<surname>Chen</surname>, <given-names>J. C.</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>, <given-names>J.</given-names>
</string-name>, &amp; <string-name>
<surname>Xu</surname>, <given-names>J. G.</given-names>
</string-name> (<year>2017</year>). <article-title>MIR‐181a involves in the hippocampus‐dependent memory formation via targeting PRKAA1</article-title>. <source xml:lang="en"/>Scientific Reports, <volume>7</volume>, <fpage>8480</fpage>
<pub-id pub-id-type="doi">10.1038/s41598-017-09095-3</pub-id>
<pub-id pub-id-type="pmid">28814760</pub-id></mixed-citation>
</ref>
<ref id="brb31199-bib-0062">
<mixed-citation id="brb31199-cit-0062" publication-type="journal">
<string-name>
<surname>Ziats</surname>, <given-names>M. N.</given-names>
</string-name>, &amp; <string-name>
<surname>Rennert</surname>, <given-names>O. M.</given-names>
</string-name> (<year>2014</year>). <article-title>Identification of differentially expressed microRNAs across the developing human brain</article-title>. <source xml:lang="en"/>Molecular Psychiatry, <volume>19</volume>, <fpage>848</fpage>–<lpage>852</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2013.93</pub-id>
<pub-id pub-id-type="pmid">23917947</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>